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A forward genetics screen in mice identified a mutation in the gene Wdpcp that leads to severe 
skeletal dysmorphogenesis with disrupted formation of the primary cilium. The primary cilium is 
a transiently formed organelle that facilitates the processing of hedgehog transcription factors 
Gli2 and Gli3. Conditional deletion of Wdpcp in the limb bud mesenchyme recapitulates the 
appendicular skeletal phenotype of the constitutive Wdpcp loss of function mutant. Loss of 
Wdpcp disrupts formation of the repressor form of Gli3, leading to hyper activation of hedgehog 
pathway. This hyper activation delays chondrogenesis via increased expression of bone 
morphogenetic protein (BMP) inhibitor Grem1, suppressing activation of BMP pathway 
necessary for chondrogenesis. Suppression of hedgehog signaling and Grem1 expression and 
concomitant rescue of chondrogenesis is demonstrated with treatment of in vitro limb bud 
micromass cultures with direct hedgehog transcription factor Gli inhibitor GANT61, but not 
hedgehog signal transducer Smoothened inhibitor. This indicates that Wdpcp functions below 
Smoothened in the hedgehog pathway and directly implicates hedgehog signaling in the 
observed chondrogenic delay. In order to determine the effects of Wdpcp loss independent of this 
observed chondrogenic delay, we generated chondrocyte specific deletion mouse model of 
Wdpcp. Loss of Wdpcp and formation of the primary cilium in chondrocytes disrupts formation 
of trabecular bone, and mouse embryonic fibroblasts (MEFs) lacking Wdpcp have diminished in 
vitro osteogenesis. Activation of hedgehog pathway in MEFs lacking Wdpcp is rescued with 
lentiviral infection with a form of Gli2 mimicking amino terminal phosphorylation. We also 
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demonstrate that overactivation of PKA in MEFs can restore disrupted formation of the repressor 
form of Gli3. These findings define an important role for Wdpcp and primary cilia in skeletal 
development and in coordinating the post-translational modification of Gli transcription factors 
necessary for normal hedgehog signaling.  
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1.0  INTRODUCTION 
1.1 DEGENERATIVE DISEASES OF THE SKELETON AND SKELETAL 
DEVELOPMENT 
Degenerative diseases of the skeletal tissues include osteoporosis and osteoarthritis. Osteoporosis 
is characterized by microarchitectural deterioration of bone and low bone mass and is a major 
risk factor for fractures of the hip, vertebrae, and distal forearm. Osteoporosis-related hip fracture 
is associated with 20% mortality and 50% permanent loss of function within one year of injury 
(Woolf and Pfleger, 2003). There are more than 2 million osteoporosis-related fractures annually 
in the United States with total costs for treatment of these fractures exceeding $19 billion (Burge 
et al., 2007). While there are several available medical therapies for osteoporosis including 
bisphosphonates (e.g. Alendronate), recombinant parathyroid hormone (e.g. Forteo), strontium 
ranelate (e.g. Protelos), and antibodies against receptor activator of NF- κβ (RANKL) (e.g. 
Denosumab), each of these therapies has its own limitations including risk of pathological 
fractures, increased incidence of bone tumors, association with adverse cardiovascular events, 
and immune dysfunction, respectively (Khosla, 2009). Conservative estimates are that 
osteoarthritis affects 21% of adults in the United States (Lawrence et al., 2008). In 2007 over 
$185 billion was spent in the United States on healthcare for the treatment of osteoarthritis 
(Kotlarz et al., 2009). With the average age of the population increasing, prevalence of this 
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disease is only expected to increase (Hootman and Helmick, 2006). Osteoarthritis is 
characterized clinically by joint pain, tenderness, occasional effusions, progressive deformity and 
loss of joint function resulting from restricted motion. These symptoms are due to progressive 
degeneration of the articular cartilage that includes fibrillation, ulceration, and eventual joint 
space narrowing. Current treatments for osteoarthritis are limited to symptomatic management 
with non-steroidal anti-inflammatory drugs, cyclooxygenase-2 inhibitors, or intra-articular 
corticosteroid injections. The only currently available treatment for advanced stage osteoarthritis 
is joint replacement, or joint arthroplasty (Zhang et al., 2008). While joint arthroplasty can 
successfully alleviate symptoms, patients undergoing joint replacement are typically unable to 
match functional abilities of their healthy counterparts following the procedure (Bade et al., 
2010). Additionally, implants are susceptible to wear and degradation and typically last only 10-
15 years, with revision surgery often required at this point. Of the nearly one million hip and 
knee replacements performed annually, 17.5% and 8.2%, respectively, will require revision at 
some point (Kurtz et al., 2007). 
The current biological approaches for repair of osteoarthritic cartilage, including 
microfracture, osteochondral autograft transplantation system (OATS), autologous chondrocyte 
implantation (ACI), matrix assisted autologous chondrocyte implantation (MACI), and 
approaches utilizing mesenchymal stem cells (MSCs) and platelet-rich plasma (PRP), have failed 
thus far to yield consistent significant enhancement of regenerative capacity or sustained 
clinically significant improvement (Anz et al., 2014). Furthermore, the use of OATS, ACI, and 
MACI is limited to focal defects, which represent a limited subset of patients with osteoarthritis 
(Rodriguez-Merchan, 2013). The inconsistency associated with MSC and PRP based approaches 
may lie in the fact that these represent heterogeneous and highly variable populations of cell 
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types and growth factors, respectively (Anz et al., 2014). In order to overcome these limitations, 
significantly more targeted and general approaches that harness a mechanistic understanding of 
cartilage biology are necessary. Stimulating the innate regenerative capacity of cartilage and/or 
correcting joint and patient specific imbalances in cartilage homeostasis with targeted therapies 
to halt or reverse the progression of osteoarthritis represent the holy grail of osteoarthritis 
treatment (Jiang and Tuan, 2014). 
The disease that is classified as osteoarthritis has complex, multifactorial origins and 
develops over long time scales, making it difficult to study. There are inflammatory, 
biomechanical, and genetic contributions to pathophysiology of osteoarthritis (Abramson and 
Attur, 2009). The pathophysiology of osteoporosis is similarly complex, with contributions from 
hormone regulation (e.g. estrogen levels in post-menopausal women), vitamin D balance, 
exercise and physiologic loading, mutations in genes important for osteoblast and osteoclast 
generation and survival, and regulation of metabolism, among many others (Burge et al., 2007). 
Severe forms of early onset arthritis have been associated with mutations in genes that are 
associated with the embryonic development of articular cartilage and synovial joints. For 
example, Gdf5 is a bone morphogenetic protein (BMP) family gene that was demonstrated to be 
integral to the development of articular cartilage and synovial joints in mouse studies of skeletal 
development (Francis-West et al., 1999). Recent genome wide association studies have 
discovered that mutations in Gdf5 are associated with severe forms of early onset osteoarthritis in 
humans (Sandell, 2012). The study of mouse knockout models of receptor activator of nuclear 
factor κβ ligand (RANKL) demonstrated the important role for this gene in regulating 
osteoclastogenesis (Dougall et al., 1999) and paved the way for the development of the RANKL 
targeted antibody, Denosumab, for treatment of osteoporosis (Rachner et al., 2011). By studying 
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mouse models in which skeletal development is disrupted, an understanding of the mechanisms 
by which cartilage and skeletal elements are formed during development and eventually achieve 
adult homeostasis can be built. Utilizing this framework, the contribution of individual genetic 
components to the pathophysiology of degenerative diseases of the skeleton can be 
systematically studied. With understanding gained from these studies, the significance of 
patient’s genetic contributions and risk factors can be modeled, allowing targeted treatments to 
be derived for effective personalized medicine.  
1.2 SKELETAL DEVELOPMENT 
1.2.1 Model organisms for study of the skeletal development 
The study of skeletal development is necessarily limited to vertebrates. This rules out the use of 
some classic model organisms used for genetics research including D. melanogaster and C. 
elegans. Many of the early studies of the molecular genetics of vertebrate skeletal development 
were carried out in chickens due to their accessibility, amenability to in ovo manipulation, and 
relative similarity to mammals. D. rerio is an organism that gained increasing traction in recent 
years for the study of axial and craniofacial skeletal development due to amenability to genetic 
knockdown with morpholino technology, and more recently, targeted genetic disruption. 
However, D. rerio are less applicable for the study of appendicular skeleton due to their genetic 
divergence from mammals (Langhans et al., 2014). Other model organisms such A. carolinesis 
(green anole) and A. mexicanum (axolotl) have also been studied (Kragl et al., 2009; Lozito and 
Tuan, 2015), but more for their differences in skeletal development and regeneration potential 
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than for their similarities to mammals. With the development of more advanced genetics 
techniques in mice such as targeted gene deletion and, later, more sophisticated methods such as 
conditional and inducible gene deletion (Gu et al., 1993), mice have become the organism of 
choice for the study of development of many tissues, including the skeleton. 
In terms of developmental biology, mice have an 18-21 day gestation period depending 
on strain. Unlike humans, mouse skeletal growth continues throughout life and mice never close 
their growth plates under normal circumstances. Despite these differences, the genetic 
similarities that exist make mice an excellent model organism to study mammalian skeletal 
development. Common, conserved genetic mechanisms have been demonstrated to underlie the 
specification and maturation of skeletal tissues at multiple stages in development (Langhans et 
al., 2014). 
1.2.2 Origins of the vertebrate skeleton 
All cells in the developing vertebrate are descended from one of three germ lineages: 
endoderm, mesoderm, and ectoderm. The mesoderm is formed during gastrulation when cells 
migrate through the primitive streak (Acloque et al., 2011). At this stage the mesoderm exists in 
multiple compartments (Figure 1). The lateral plate mesoderm, with contributions from the 
paraxial mesoderm derived somites for tendon and ligaments, eventually gives rise to the 
appendicular skeleton and pelvis (Malashichev et al., 2008). Mesenchymal precursor cells in the 
limb are marked by expression of Prx1 (Logan et al., 2002). The axial mesoderm gives rise to the 
notochord, which contributes towards the formation of the nucleus pulposus (NP) of the 
intervertebral discs (IVD). The paraxial mesoderm gives rise to the somites that will form the 
ribs, vertebral bodies, annulus fibrosus of the IVD (Smith et al., 2011), and part of the 
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craniofacial skeletal tissues. The majority of the craniofacial skeletal tissues are derived from 
neural crest cells, a population of cells that derives from the ectoderm adjacent to the neural tube 
(Abzhanov et al., 2007). 
 
 
Figure 1. Developmental origins of the vertebrate skeleton.  
The three embryonic germ layers, endoderm (yellow), mesoderm (orange), and ectoderm (blue), are formed during 
the process of gastrulation. The vertebrate skeleton is derived from mesoderm and ectodermal neural crest. The 
craniofacial skeleton is derived from neural crest, while the axial and appendicular skeletons are derived from 
mesoderm.  
1.2.3 Appendicular skeletal development 
The development of the appendicular skeleton begins at embryonic day 9.0 in mice with the 
formation of the forelimb ridges (Figure 2). The hindlimb ridges lag behind the forelimbs by 
about 18 hours and form at embryonic day 9.75 due to the rostro-caudal progression of 
development. The outgrowth of the limb bud is governed by two major signaling centers: the 
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apical ectodermal ridge (AER) and the zone of polarizing activity (ZPA) (Figure 2). The AER is 
a specialized ectodermal signaling structure that runs along the dorsoventral edge of the distal 
edge of the limb bud. The AER arises from the epithelial ectoderm overlying the lateral plate 
mesoderm and secretes fibroblast growth factors (FGFs) that initiate limb bud outgrowth. The 
ZPA arises at the posterior aspect of the limb bud at E9.5 and secrets sonic hedgehog protein 
(Shh). This secreted Shh has effect of both encouraging limb bud outgrowth by sustaining the 
AER and patterning the anterior/posterior axis of limb by providing a signaling gradient that 
interacts with and reinforces other pathways controlling this patterning. Interactions between the 
ZPA, AER, and limb mesenchyme regulate the outgrowth of the limb and the initiation of 
chondrogenesis at E11.0. At E11.0 mesenchymal condensation takes place to initiate 
chondrogenesis and chondrocyte differentiation (Pignatti et al., 2014).  
Chondrocytes at the center of the cartilage model are the first to hypertrophy and begin 
secreting signals that set up the structure of the growth plate, a transient developmental structure 
that eventually closes via endochondral ossification, that takes place during puberty in humans. 
The growth plate is a highly organized arrangement of chondrocytes that includes a resting zone, 
a proliferating zone, a pre-hypertrophic zone, and cell polarity a hypertrophic zone. Resting and 
proliferating chondrocytes are marked by expression of parathyroid hormone related peptide 
(PTHrP), which is known to inhibit chondrocyte hypertrophy. Proliferating chondrocytes are 
organized into columns of cells oriented with the long axis towards the hypertrophic region, and 
this organization is essential for the control of bone shape. The stacking of proliferating 
chondrocytes is believed to involve elements of planar cell polarity, primary cilium orientation, 
matrix proteins, and diffusion gradients of growth factors such as BMPs, Indian hedgehog (Ihh), 
and Wnts and is an area of active investigation (Kuss et al., 2014). Early pre-hypertrophic 
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chondrocytes are marked by expression of Ihh. As the cells enlarge and enter into hypertrophy 
(Figure 2), they are marked by expression of the matrix protein, collagen type X (Col10a1). 
Additionally, they express a number of genes necessary for facilitating the remodeling of the 
ECM for blood vessel and osteoblast invasion, including matrix metalloproteinases (Mmp9 and 
Mmp13) and vasculoendothelial growth factor (Vegfa). Hypertrophic chondrocytes are also 
marked by expression of the early osteoblast transcription factors Runx2 and Osterix (Sp7). 
More mature hypertrophic chondrocytes also express apoptosis markers, such as Bcl2. 
Osteogenesis and the process of ossification in the forelimb begins at E14.0 with the 
differentiation of perichondrial cells adjacent to the hypertrophic chondrocytes into osteoblasts. 
Together with vascular endothelial cells these precursors invade and remodel the hypertrophic 
cartilage matrix to mature bone (Kronenberg, 2003). 
Figure 2. Development of appendicular skeleton  
The appendicular skeleton arises at E9.0 with outgrowth of the lateral plate mesoderm (gray) through signaling 
interactions with the overlying ectoderm (orange) to form the forelimb ridge. By E10.5 the outgrowth has enlarged 
to form the limb bud. Mesenchymal condensation and the beginning of chondrogenesis occurs at E11.0. 
Chondrocytes at the center of mesenchymal condensations continue to differentiate and hypertrophy to set up the 
endochondral growth plate. Vascular invasion and osteogenesis initiates at E14.0.  
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1.3 IMPORTANT SIGNALING PATHWAYS IN SKELETAL DEVELOPMENT 
1.3.1 Hedgehog signaling 
1.3.1.1 Hedgehog receptors and ligands 
Hedgehog (Hh) was first identified in D. melanogaster genetic screens in 1980 by Christiane 
Nüsslein-Volhard and Eric Weischaus (Nusslein-Volhard and Wieschaus, 1980) in work that 
would contribute to their 1995 Nobel Prize in Medicine. It was not until 1992 that the D. 
melanogaster Hh gene was independently cloned and molecularly identified as a secreted protein 
by three laboratories (Lee et al., 1992; Mohler and Vani, 1992; Tabata et al., 1992). 
Evolutionarily conserved vertebrate homologs sonic hedgehog (Shh), indian hedgehog (Ihh), and 
desert hedgehog (Dhh) were subsequently identified and their roles in development characterized 
(Chang et al., 1994; Echelard et al., 1993; Krauss et al., 1993; Riddle et al., 1993; Roelink et al., 
1994). The key Hh ligands in skeletal development are Shh and Ihh. Shh was demonstrated to 
play a key role in limb development, where it was shown to be capable of reproducing the action 
of the zone of polarizing activity (ZPA) (Cohn and Tickle, 1996), and in the patterning of neural 
tube, where it was shown to be capable of reproducing the action of the notochord and floor plate 
(Jessell, 2000), with grafting and bead experiments. Ihh was shown to play a central role in 
organization of the growth plate and formation of bones via the process of osteogenesis 
(Kronenberg, 2003).  
A number of secreted inhibitors and matrix proteins play important roles in regulating the 
levels of hedgehog signaling by binding and sequestering hedgehog ligands. Hhip is a secreted 
inhibitor of hedgehog that binds and sequesters hedgehog to prevent its activity within the limb 
bud (Chuang and McMahon, 1999).  
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Hedgehog proteins bind to the frizzled domain containing membrane protein receptors 
Ptch1 and Ptch2. Both Ptch1 and Ptch2 interact with all hedgehog proteins with similar affinity. 
While Ptch1 is expressed ubiquitously throughout the embryo, high levels of Ptch2 expression 
are restricted to the skin and germ cells (Carpenter et al., 1998). Ptch1 and Ptch2 both form a 
complex with another hedgehog pathway component, the membrane receptor Smo. When 
hedgehog ligand is not present and the pathway is inactive, Ptch binds to Smo and inhibits 
activation of the Hh pathway by inhibiting Smo (Figure 4). When hedgehog ligand is present, 
Ptch mediated inhibition of Smo is alleviated and the Hh pathway is activated. Animals lacking 
functional Ptch1 displayed constitutively active hedgehog pathway activity while animals 
lacking function Smo display constitutively inactive hedgehog pathway activity. Hhip and Ptch1 
expression are increased with increased hedgehog activity and serves as a negative feedback 
control loop to limit hedgehog signaling in vivo (Briscoe and Therond, 2013; Goodrich et al., 
1996). 
1.3.1.2 Gli transcription factors 
The protein cubitus interruptus (Ci) was initially identified in D. melanogaster as the target of 
hedgehog signaling. Ci is post-translationally processed to either a labile transcriptional activator 
when the hedgehog pathway is activated or a truncated repressor with the C-terminal activation 
domain removed when the hedgehog pathway is quiescent (Ohlmeyer and Kalderon, 1998).  
In mammals, the Gli transcription factors (Gli1-3) were shown to be homologs of the D. 
melanogaster hedgehog target transcription factor Ci. Gli1 is not processed, and contains only 
the activation domain (Dai et al., 1999; Sasaki et al., 1999). Gli1 has been shown to function 
primarily as a molecular rheostat for the hedgehog pathway, serving as a positive feedback loop. 
Activation of the hedgehog pathway corresponds with increased expression of Gli1 (Dai et al., 
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1999).  
Gli2 and Gli3 share the most homology to Ci and have the more severe knockout 
phenotypes compared to Gli1 (Park et al., 2000). Unlike Gli1, both Gli2 and Gli3 are 
proteolytically processed to repressor forms when the hedgehog pathway is quiescent (Pan et al., 
2006). Gli2 and Gli3 contain N-terminal transcriptional repressor domains and zinc-finger DNA 
binding domains and C-terminal transcriptional activation domains. Proteolytic cleavage 
removes the C-terminal activation domain generating an N-terminal repressor that competes with 
the full-length activator for binding at Gli target sites (Tsanev et al., 2009). The activity of the 
hedgehog pathway is thus dictated by the balance of Gli repressor and activator bound to Gli 
target sites in the DNA. Because Gli3 is more readily proteolytically processed than Gli2, Gli3 
serves as the primary repressor form while Gli2 serves as the primary activator form in mammals 
(Sasaki et al., 1999). 
1.3.1.3 Post-translational modifications of Gli 
The output of the hedgehog pathway is modified by a number of pathways that affect the post-
translational modification of the Gli transcription factors. Identified post-translational 
modifications of Gli proteins include phosphorylation, ubiquitinylation, and sumoylation (Cox et 
al., 2010; Niewiadomski et al., 2014; Zhang et al., 2013) (Figure 3).   
Phosphorylation was one of the first identified post-translational modifications of Gli. 
Knockout studies in D. melanogaster demonstrated that PKA and GSK3 were negative regulators 
of the hedgehog pathway. It was noted that mutants bearing mutations in PKA and/or GSK3 
displayed ectopic activation of the Hh pathway. GSK3-/- flies exhibited accumulation of full-
length Ci and ectopic Hedgehog target gene expression. While Smo-/- animals displayed 
decreased full length Ci accumulation due to constitutive processing of Ci and hedgehog path 
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silencing, GSK3-/-;Smo-/- mutants accumulated high levels of full length Ci and rescued the 
constitutive silencing of Hh target gene expression in Smo-/- mutants. This indicates that GSK3 
functions downstream of Smo in the Hh pathway (Jiang and Struhl, 1996) (Figure 4).  
Conversely, overexpression of constitutively activated PKA blocked accumulation of 
Ci155. Overexpression of constitutively activated PKA with concomitant treatment with GSK3 
inhibitor resulted in accumulation of full length Ci, indicating that both PKA and GSK3 are 
required for full length Ci processing. Studies with mutant forms of Ci demonstrated that GSK3 
can phosphorylate Ci only after PKA has phosphorylated Ci (Jia et al., 2002). Analogous 
findings with mammalian homologs Gli2 and Gli3 have demonstrated the same regulation of Gli 
processing by PKA and GSK3B (Pan et al., 2006; Wen et al., 2010). 
Recently, the effects of phosphorylation on Gli activity have been explored in detail with 
residue specific mutant forms of Gli2 and Gli3. Transfection of a Gli2 with mutations of C-
terminal PKA sites, Cki sites, or GSK3 sites that abolished their ability to be phosphorylated 
resulted in increased hedgehog activity versus transfection of wild type Gli2, indicating specific 
sites of phosphorylation that modify Gli activity (Pan et al., 2006). While phosphorylation of C-
terminal domain was demonstrated to encourage Gli processing and repress hedgehog activity, a 
recent study demonstrated that phosphorylation of the N-terminal domain blocks Gli processing 
and activates hedgehog activity (Niewiadomski et al., 2014). These findings highlight the fact 
that phosphorylation of Gli is a tightly regulated process that lies at the center of the regulation 
and output of the hedgehog signaling pathway. 
In addition to phosphorylation, Gli transcription factors have also been demonstrated to 
undergo additional modifications including ubiquitinylation and sumoylation. The ubiquitin E3 
ligase Btrc interacts directly with phosphorylated Gli to facilitate its degradation via 
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ubiquitinylation (Pan et al., 2006). Btrc-/- animals display ectopic hedgehog signaling and 
defective processing of Gli to shortened repressor (Jiang and Struhl, 1998). Mutation of lysines 
in the C-terminal domain having demonstrated that ubiquitinylation is required for normal Gli 
processing and degradation (Kent et al., 2006). Different patterns of ubiquitylation (K-11 versus 
K-48 linked) have been demonstrated to control the partial processing versus total degradation of 
Gli, but the mechanism by which Gli is specified to one fate versus the other has not been fully 
elucidated (Zhang et al., 2013) (Figure 3). Sumoylation of Gli transcription factors has been 
demonstrated to regulate activator potential. Furthermore, this regulation of activator potential 
was identified to occur downstream of PKA (Cox et al., 2010) (Figure 4). 
 
Figure 3. Domain structure and post-translational modification sites of Gli2/3.  
Gli2 and Gli3 are post-translationally modified to affect their transcriptional activity. Phosphorylation and 
ubiquitylation sites have been identified and demonstrated to control maturation of both the activator form of Gli 
and the processing to the truncated repressor form. 
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Figure 4. Hedgehog signaling pathway.  
Hedgehog signaling output is mediated by the balance of Gli repressor versus Gli activator levels. When quiescent, 
Ptch inhibits the activity of Smo, allowing Gli3 to be processed to a repressor form and preventing the conversion of 
Gli2 to activator form. When Hh is present and the pathway is activated, Ptch inhibition of Smo is relieved and Smo 
inhibits the proteolytic processing of Gli3 while promoting the conversion of Gli2 to activator form.  
 15 
1.3.2 BMP signaling 
1.3.2.1 BMP ligands and antagonists 
Bone morphogenetic proteins (BMPs) were first identified by their ability to induce ectopic bone 
upon subcutaneous application (Urist, 1965). Subsequent studies identified BMP ligands as 
members of the TGFβ superfamily and identified a number of important functions for them in 
both embryonic and postnatal development (Hinck, 2012). Twelve BMP ligands have been 
identified in mammals that can form homo- and heterodimers with different affinities for their 
receptors. BMP ligands are activated upon secretion by cleavage, at which point they can interact 
with both receptors and BMP antagonists. Twelve BMP antagonists have been identified in 
mammals and they have also been shown to play important roles in development. These 
antagonists function by binding and sequestering BMP ligands to prevent their interaction with 
receptors (Miyazono et al., 2010; Walsh et al., 2010). BMPs expressed in the developing limb 
include Bmp2, Bmp4, and Bmp7. The inhibitor Noggin is dynamically regulated during skeletal 
development and expression occurs after the onset of chondrogenesis (Benazet et al., 2009). The 
BMP antagonist Grem1 plays an important in the developing limb bud as a component of the 
Shh-Grem-AER/FGF signaling feedback loop that controls limb bud outgrowth and 
chondrogenesis (Pignatti et al., 2014).  
1.3.2.2 BMP receptors and signal transduction 
BMP receptors are transmembrane glycoproteins with serine-threonine kinase activity. BMP 
ligand dimers bind to type II BMP receptors (Figure 5) resulting in recruitment and 
phosphorylation of type I BMP receptors. Phosphorylation of type I BMP receptors triggers 
phosphorylation of the receptor associated Smads (R-Smads) (Smad1, Smad5, and Smad8/9). 
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These phosphorylated R-Smads are capable of translocation to the nucleus with the Smad4 co-
receptor where they activate expression of BMP target genes (Pignatti et al., 2014). In the 
developing limb bud, Msx2 is a direct target of BMP signaling in the developing limb, and can 
be used as a reporter for BMP activity (Pizette et al., 2001). Bmpr1a and Bmpr2 are both 
expressed highly in limb bud. Smad1, Smad5, Smad8, and Smad4 are expressed uniformly 
throughout the limb bud (Benazet et al., 2012; Wong et al., 2012).  
 
Figure 5. BMP signaling 
pathway 
BMP ligand dimers (BMP2/4/7) 
act as ligands for type I and type 
II BMP receptors. Extra-cellular 
antagonists such as Grem1 and 
Noggin inhibit BMP pathway 
activity by binding BMP ligands 
and preventing their interaction 
with receptors. BMP receptors 
are transmembrane 
glycoproteins with serine-
threonine kinase activity. 
Binding of type II BMP 
receptors to BMP ligands results 
in recruitment and 
phosphorylation of BMP type I 
receptors. These phosphorylated 
receptors phosphorylate 
receptor associated SMADs (R-
SMADS) in the cytoplasm. R-
SMADs for a complex with co-
SMAD and translocate to the 
nucleus to activate transcription 
of BMP target gene Msx2. 
(Reproduced with permission 
from Pignatti et al 2014). 
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1.4 CHONDROGENESIS 
1.4.1 Shh and Gli in the limb bud 
The hedgehog signaling pathway plays a central role in multiple processes in the developing 
limb bud. One of the earliest roles for hedgehog signaling in the limb bud is facilitating limb bud 
outgrowth. As the AER develops and begins to secrete Fgf4 and Fgf8 that stimulate limb bud 
mesenchyme to proliferate and migrate into the limb bud, it also stimulates the expression of Shh 
in the ZPA. The expression of Shh, in turn stimulates expression of Fgfs from the AER. This 
results in a positive feedback loop between Shh-Grem1-AER/Fgfs that promotes limb bud 
outgrowth (Benazet and Zeller, 2009; Zeller et al., 2009). Both ectopic early activation of 
hedgehog signaling as well as failure to fully activate hedgehog signaling can disturb this 
feedback loop resulting in defective limb bud outgrowth (Bastida et al., 2009; Zhu et al., 2008; 
Zhulyn et al., 2014). 
The role of hedgehog and Gli3 in anterior/posterior limb patterning is closely tied to limb 
bud outgrowth and is one of the most extensively studied areas of limb development (Figure 7). 
One of the first described skeletal mutant mouse models was the extra-toes (Xt) mutant, which 
carries a null allele of Gli3 to function as a Gli3-/- mouse. The Xt mutant displays severe 
polydactyly (Johnson, 1967). Further studies revealed that Gli3 is a key mediator of anterior 
posterior patterning in the developing limb bud and acts primarily as a repressor in this context. 
Prx1Cre;Gli3701C mice were engineered to overexpress the repressor form of Gli3 in limb 
mesenchyme. In contrast to the polydactyly observed in Xt mutant, these mice have shortened 
limbs with single digit oligodactyly. They display significant decreases in expression of 
hedgehog markers Gli1 and Ptch1 (Cao et al., 2013). These mice have a nearly identical 
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phenotype to the Shh-/- mice, which also display shortened limbs with oligodactyly. Expression 
patterns of Gli3 and Shh appear to be mutually exclusive in the limb bud. The Xt mutant has 
ectopic expression of Shh in the anterior forelimb bud at E11.0 and E12.0 This ectopic Shh 
expression is accompanied by ectopic anterior expression of the hedgehog receptor and reporter 
gene Ptch1 (Buscher et al., 1997). The Shh-/-;Gli3-/- double mutant displays a phenotype identical 
to the Xt mutant, indicating that Shh functions above Gli3 in the determination of digit number 
and functions independently of Shh to determine digit number (te Welscher et al., 2002). Gli3R 
was later demonstrated to interact with Hoxd genes and Hand2 to regulate digit patterning 
(Buscher et al., 1997; Chen et al., 2004; Osterwalder et al., 2014; te Welscher et al., 2002).  
Gli2-/- mice demonstrate outgrowth defects with shortened humerus, radius, and ulna in 
the forelimb. However, they do not have overt A/P patterning defects. Gli2-/-;Gli3-/- mice display 
more severe outgrowth defects and long bone shortening than Gli2-/- mice. These findings 
demonstrate that both Gli3 repression and Gli2 activation play important roles in skeletal 
development (Mo et al., 1997). 
1.4.2 BMP and Grem1 in the limb bud 
BMP signaling plays a key role in mediating skeletal development in the limb. Formation of the 
AER is dependent upon Bmp4 signaling through Bmpr1a. Msx2-Cre;Bmpr1aflox/flox mice have 
ectodermal specific deletion of Bmpr1a and display failure of the AER maintenance and limb 
bud outgrowth. Prx1-Cre;Bmpr1aflox/flox mice with limb bud mesenchyme deletion of Bmpr1a 
display shortened limbs with decreased cell proliferation that results in complete agenesis of the 
autopod. Reduced expression of BMP target genes Msx1 and Msx2 in these mice coincided with 
ectopic anterior hedgehog signaling (Ovchinnikov et al., 2006). Prx1-Cre;Bmp4flox/flox mice have 
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limb mesenchyme specific deletion of the main BMP in limb bud development, Bmp4, and 
display polydactyly with delayed induction of the AER and expanded Shh expression (Selever et 
al., 2004).  
The Prx1Cre;RosadGrem1 mouse overexpresses Grem1 within limb mesenchyme and 
displays significant polydactyly. As expected with overexpression of the BMP inhibitor Grem1, 
limb buds of these mice display decreased expression of BMP target gene Msx2 and decreased 
levels of phospho-Smad1/5/8 characteristic of decreased BMP pathway activation. Shh 
expression also showed a significant increase without any ectopic anterior expression. These 
expression changes coincided with an increase in proliferation and decrease in chondrogenic 
differentiation as measured by expression of chondrogenic marker gene Sox9 at E12.5. 
Additionally, using a mouse model with an early inducible Cre in the limb bud (Hoxb6-
CreER;RosadGrem1) it was shown that the development of polydactyly depends on overexpression 
of Grem1 in a critical window between E10 and E11.5 (Norrie et al., 2014).  
The expression of Grem1 in the limb bud was recently found to be under control of a 
distant cis-regulatory region (GRS1) in the limb bud. Underlying the coordination present 
between hedgehog and BMP signaling in the limb bud, GRS1 input on Grem1 depends on Shh 
signaling and is modulated by BMP signaling. Chromatin immunoprecipitation revealed that 
Gli3 binds to core regulatory elements in GRS1 (Zuniga et al., 2012). 
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Figure 6. Hedgehog, Gli3 repressor, and BMP in the limb bud 
A series of studies that utilize transgenic and targeted knockout mice have revealed that Gli3 repressor levels in the 
limb are modified by hedgehog signaling activation and serve to control the timing of the exit of proliferating limb 
bud progenitors to chondrogenesis. Delayed exit results in more digits (polydactyly) while early exit results in fewer 
digits (oligodactyly). BMP signaling is also able to influence this process with overactivation of BMP signaling 
resulting in oligodactyly and underactivation resulting in polydactyly. 
1.4.3 Coordinated signaling in chondrogenesis 
Hedgehog signaling and BMP signaling play significant roles in the initiation of chondrogenesis. 
Initiation of chondrogenesis in the limb bud is closely coordinated with both outgrowth and 
anterior/posterior patterning. The polydactyly displayed by Gli3-/- mice is closely associated with 
delayed chondrogenesis in the anterior limb bud. Deletion of Gli3 leads to increased expression 
of proliferation markers Ccnd1 and Cdk6 concomitant with decreased expression of 
chondrogenic markers Col2a1 and Noggin. The decrease in expression of chondrogenic markers 
coincides with decreased expression of BMP target genes Msx2 and Id1 along with increased 
expression of the BMP inhibitor Grem1. Furthermore, polydactyly and chondrogenic delay in 
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Gli3-/- mice is rescued in Gli3-/-;Grem1+/- mice and exacerbated in Gli3-/-;Bmp4+/- mice.  These 
findings demonstrate that Gli3 levels and hedgehog signaling modulate the activity of the BMP 
signaling pathway to control chondrogenesis (Lopez-Rios et al., 2012).  
Concordantly, Prx1Cre;Ptch1flox/flox mice with constitutive activation of hedgehog 
signaling in the limb mesenchyme display polydactyly. Increased hedgehog signaling decreases 
the level of Gli3R and leads to an increase in Grem1 expression with corresponding observed 
decrease in expression of BMP target gene Msx1 (Butterfield et al., 2009). Prx1-Cre;Ptch1flox/flox 
mice also display delayed onset of chondrogenesis evidenced by Alcian blue staining and 
expression of chondrogenic marker gene Col2a1 at E12.5. In vitro micromass demonstrated 
increased hedgehog signaling was associated with inhibition of chondrogenesis as assayed by 
Alcian blue staining. For the Prx1-Cre;Ptch1flox/flox mice, deficits in chondrogenesis could be 
rescued by treatment with Smo inhibitor cyclopamine. Expression of chondrogenic markers 
Sox5, Sox6, Sox9 and Col2a1 was variable with Prx1Cre;Ptch1flox/flox micromasses, with 
expression compared to controls higher at day 2 but lower at day 4 of culture (Bruce et al., 
2010). These findings taken together form a model of limb bud signaling where outgrowth, 
patterning, and chondrogenesis are controlled by a signaling feed back loop that involves Shh 
control of Gli3R levels modulating BMP signaling to control chondrogenesis (Figure 8).  
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Figure 7. Hedgehog  modulates BMP activity to control onset of chondrogenesis and exit to proliferation 
The onset of chondrogenesis in the limb bud is closely balanced with continued proliferation to achieve the intended 
form of the limb. The ability of alterations in BMP signaling level to influence this process in a Gli3-/- background 
indicates that BMP signaling acts downstream of Gli3 in this process in the limb bud. 
 
 
Figure 8. BMP signaling controls limb bud chondrogenesis 
The initiation of chondrogenesis within the limb bud is controlled by the action of BMP signaling. A feedback loop 
between Shh, Grem1, and AER FGFs regulates the levels of Grem1 within the developing limb bud to suppress 
BMP activity. BMP4 signaling through BMPR1A is necessary to initiate formation of the AER and limb bud 
outgrowth. Following formation of the AER (red), FGFs from the AER can sustain Shh signaling from the ZPA 
(green). Shh from the ZPA drives the expression of both limb mesenchyme BMPs and BMP inhibitor Grem1. 
Grem1 inhibits the action of BMPs to maintain the limb bud in a proliferative state and prevent chondrogenesis. 
When anterior progenitors have a large enough spatial separation from Shh of the ZPA, hedgehog repressor Gli3R 
levels rise to suppress Grem1 expression with FGFs, allowing BMP activity to rise and chondrogenesis to initiate. 
(Adapted from Pignatti et al 2014). 
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1.5 OSTEOGENESIS 
Developmentally, bone is formed by two fundamental processes: endochondral ossification and 
intramembranous ossification. As described above, endochondral ossification involves the 
formation of the growth plate, a spatially organized structure within which chondrocytes mature 
through oriented proliferation, hypertrophy, and eventually either apoptosis or differentiation 
into osteoblasts; invading osteoblastic progenitor cells then populate the skeletal model, giving 
rise to a fully formed bone. In contrast, intramembranous ossification involves the direct 
conversion of mesenchymal progenitors to osteoblasts without the intervening chondrocyte 
maturation or growth plate structure, and involves the gradual fusion of clusters of osteoblasts 
known as spicules. The axial and craniofacial skeletons are formed primarily via 
intramembranous ossification (Abzhanov et al., 2007). 
Mature bone is composed of three types of cells: osteoblasts, osteocytes, and osteoclasts. 
Osteoclasts, responsible for bone resorption, are derived from hematopoietic stem cells. Their 
regulation and differentiation are tightly linked to osteoblasts and systemic regulators (Asagiri 
and Takayanagi, 2007). Osteoblasts, responsible for bone synthesis, are derived from Sox9+ 
mesenchymal progenitors that can either continue as chondrocytes or differentiate to 
preosteoblasts (Akiyama et al., 2005) under the influence of the transcription factors Runx2, and 
later, Osterix (Sp7). Runx2 and Sp7 are often used as markers of osteoblast differentiation 
(Figure 9). Mature osteoblasts express the transcription factor activating transcription factor 4 
(Atf4). Atf4 is a direct regulator of osteocalcin (Ocn) and stimulates expression of Ihh in 
chondrocytes to encourage maturation and osteoblast differentiation (Long, 2012). Osteoblasts 
that become embedded within the bony matrix continue to differentiate into osteocytes. 
Osteocytes, marked by the expression of sclerostin (Sost) and dentin matrix protein 1 (Dmp1), 
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compose more than 90% of all mature bone cells and play important roles in signaling to control 
calcium balance and bone remodeling in response to mechanical and hormonal cues via control 
of osteoblast and osteoclast differentiation (Bonewald, 2011). 
The in vivo hallmark of osteoblastic cells is their ability to lay down a calcified bony 
matrix. This matrix is composed primarily of type I collagen (Col1a1) along with Ocn. 
Calcification requires the expression of alkaline phosphatase (Alpl) to provided the necessary 
phosphate for forming hydroxyapatite along with a host of matrix proteins that support the 
formation of calcified matrix including osteonectin (Sparc), integrin binding sialoprotein (Ibsp), 
and osteopontin (Spp1) (Long, 2012). 
A number of signaling pathways control the differentiation of osteoblasts. Ihh expression 
is essential for bone formation—loss of Ihh in mice results in complete failure of bony 
ossification (St-Jacques et al., 1999). Mutations in the Notch signaling pathway demonstrate that 
Notch signaling suppresses osteoblast differentiation. Loss of function mutations in the Wnt co-
receptor Lrp5 result in severe osteoporosis, and the canonical Wnt transcription factor β-catenin 
is required for bone formation in the embryo. A critical threshold of BMP signaling is required 
for differentiation of mature osteoblasts, but the roles of different receptors and ligands is still an 
area of active research. FGF signaling plays a role in preosteoblast proliferation and mature 
osteoblast differentiation, but the precise temporal specificity remains to be investigated (Long, 
2012). 
The Ihh/PTHrP feedback loop is a major regulator of growth plate chondrocyte 
hypertrophy and osteogenesis. Ihh secreted by the pre-hypertrophic chondrocytes stimulates 
hypertrophy of proliferating chondrocytes, but also stimulates expression of PTHrP, which 
inhibits chondrocyte hypertrophy. The interplay of these two signals sets up the orderly 
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progression of chondrocytes through the growth plate (Vortkamp, 2001; Yeung Tsang et al., 
2014). Complete inactivation of hedgehog signaling in osteoblast precursors via deletion of Smo 
from the perichondrium prevents formation of normal bone collar and primary spongiosa. 
Additionally, chimeric embryos containing Smo-/- cells show no contribution of Smo-/- cells to 
perichondrium or primary spongiosa (Long et al., 2004). Gli1-/- mice display impaired bone 
formation and perichondrial osteoblast precursors fail to express osteoblast marker genes Runx2 
or Osx. Additionally, in vitro over expression of Gli1 upregulates early osteogenesis genes Alp, 
Bsp, Ocn in both wild type and Runx2-/- perichondrial cells via direct binding with the 5' regions 
of these genes. Gil1-/- mesenchymal progenitors also display decreased alkaline phosphatase 
activity in response to Smo agonist treatment (Hojo et al., 2012). 
 
 
Figure 9. Markers of osteogenic differentiation. 
Mesenchymal progenitors express specific osteogenesis related transcription factor and matrix protein genes in a 
temporally defined manner during osteoblast differentiation. Increases in expression of these markers can be used 
with in vitro osteogenesis assays to determine osteogenic differentiation. 
1.6 PRIMARY CILIA 
1.6.1 Primary cilia structure and function 
The primary cilium (Figure 10) is a transient organelle that is present on almost all cells in the 
body at some point. During the G0 phase of the cell cycle, the primary cilium is formed from one 
of the centrioles, which serves as the basal body upon which the ciliary microtubule axoneme is 
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extended. Extension of the ciliary axoneme requires a number of proteins and protein complexes. 
Intraflagellar (IFT) complex A proteins transport cargo towards the tip of the cilium while IFT 
complex B proteins transport them from the tip back to basal body.  IFT proteins coordinate with 
dynein and kinesin motors to orchestrate their movement down the microtubule axoneme 
(Garcia-Gonzalo and Reiter, 2012). At the base of the cilium a number of protein complexes 
regulate the entry into the ciliary compartment and transition zone between the basal body and 
axoneme. Identified complexes include the BBsome, which controls IFT assembly and 
turnaround (Wei et al., 2012), the NPHP module, the MKS/JBTS module, and a number of 
proteins that span between complexes, as well as a number of whose function is unknown 
(Ishikawa et al., 2012). The primary cilium and primary cilium membrane are a specialized 
compartment that is separated from the rest of the cell by a septin diffusion barrier, the assembly 
of which depends upon the planar cell polarity effector Wdpcp (Mostowy and Cossart, 2012).   
The primary cilium serves as a signaling hub for a myriad of pathways including 
hedgehog signaling, Wnt signaling, TGFβ signaling, mechanotransduction, and many others. 
Disruption of ciliogenesis occurs with disruption of any of the complexes necessary for 
ciliogenesis and is accompanied by severe phenotypes in both model organisms and humans. 
Diseases associated with dysfunctional ciliogenesis are characterized as ciliopathies and include 
polycystic kidney disease, Joubert Syndrome, Meckel-Gruber Syndrome, Alstrom Syndrome, 
and Bardet-Biedl Syndrome. The phenotypes associated with these ciliopathies affect almost all 
organ systems and include renal defects, gut malformations, congenital heart defects, deafness, 
blindness, and skeletal dysmorphogenesis (Goetz and Anderson, 2010). 
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Figure 10. Primary cilium structure. 
Primary cilia are a transiently formed organelle present on almost all cells at some point. They are composed of an 
axoneme which is extended from a basal body. The axoneme (red) composed of 9 microtubules. This structure stains 
positive for acetylated α-tubilin by immunochemistry. The basal body (green) is formed from one of two centrioles 
present in all cells and stains positive for γ-tubulin by immunochemistry. Wdpcp localizes to the basal body (light 
green) and is necessary for the formation of a septin diffusion barrier (dark green) that serves to demarcate the 
primary cilium compartment. 
1.6.2 Role in hedgehog signaling 
The primary cilium plays a central role in the hedgehog signaling pathway. Components of the 
hedgehog pathway are dynamically localized to the primary cilium and rely on the formation of 
the primary cilium for normal signaling. In Ptch1-/- MEFs there is constitutive activation of 
hedgehog signaling and constitutive localization of Smo to primary cilia. Reintroduction of 
Ptch1 demonstrates that Ptch1 prevents the accumulation of Smo in cilia in the absence of 
hedgehog ligand (Rohatgi et al., 2007). Smo is enriched in the primary cilium on hedgehog 
activation, displacing Ptch1 (Corbit et al., 2005; Wen et al., 2010).  
Gli2 and Gli3 also dynamically localize to the primary cilium. Gli2 and Gli3 are present 
at the cilia tip within 5 minutes of hedgehog activation. PKA stimulation with forskolin inhibits 
Gli3 accumulation within the cilium as does Smo inhibition with cyclopamine (Wen et al., 
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2010). Overexpressed Gli1/Gli2/Gli3 all localize to primary cilia of limb bud cells (Haycraft et 
al., 2005) 
In addition to being necessary for ciliogenesis, intraflagellar transport and kinesin motor 
proteins have shown to be necessary for hedgehog signaling. IFT proteins are required for 
formation of both Gli activator forms and repressor forms, indicating that the primary cilium 
plays a role in both of these processes (Huangfu and Anderson, 2005; Liu et al., 2005). Kif3a-/- 
mice display a homogenously partially ventralized neural tube with a low level of hedgehog 
activity that corresponds with expression of Nkx2.3 and reduced expression Hh signaling 
markers Gli1 and Ptch1. Additionally, Kif3a-/- mouse embryonic fibroblasts (MEFs) are 
unresponsive to Hh agonists (Huangfu et al., 2003). 
PKA localizes to the base of the primary cilium (Tuson et al., 2011). More recent studies 
have identified negative regulators of PKA activity such as Tulp3, pituitary adenylate cyclase 
activating polypeptide (PACAP) (Niewiadomski et al., 2013), and Gpr161 that are localized to 
primary cilia and affect hedgehog signaling. Tulp3 binds to and interacts with IFT complex A, 
and Gpr161 localizes to the primary cilium in an IFT complex A and Tulp3 dependent manner 
(Mukhopadhyay et al., 2013).  
These studies demonstrate that the primary cilium serves as important scaffold for 
hedgehog signaling. The specific mechanisms by which post-translational modification of Gli 
and hedgehog pathway output is controlled by these components will likely prove to intimately 
involve this organelle. 
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1.6.3 Primary cilia in skeletal development 
Primary cilia have been shown to play essential roles in multiple aspects of skeletal 
development. Primary cilia are present on both limb ectoderm and limb mesoderm in the E11.5 
limb bud. Analysis of the Ift88Tg737/Polaris mutant, which carries a mutant allele of the IFT 
complex B protein Ift88 that disrupts ciliogenesis, shows decreased expression levels of Gli1 and 
Ptch1 in E10.5 posterior limb bud and decreased responsiveness to exogenous Shh conditioned 
medium. These findings were associated with decreased Gli3 processing as evidenced by 
inability of exogenous Gli3-GFP to suppress Gli1 expression. It also associated with decreased 
Gli2 activation as evidenced by the inability of exogenous Gli2-GFP to induce Gli1 expression 
(Haycraft et al., 2005).  
Msx2-Cre;Ift88flox/flox mice display no overt phenotype, indicating that primary cilia 
function primarily in limb bud mesenchyme during skeletal development. Prx1-Cre;Ift88flox/flox 
mice display polydactyly and shortened limbs with expanded expression of Grem1 and decreased 
expression of Gli. Growth plates of these animals also displayed decreased expression of Ptch1 
and Gli1 characteristic of hedgehog pathway dysfunction. Mutants at E18.5 also display 
shortened limbs with reduced size of growth regions and poorly formed marrow cavity (Haycraft 
et al., 2007). Dysfunctional growth plate organization was also observed in the Tg737orpk mouse 
which carries a hypomorphic allele of Ift88 (McGlashan et al., 2007). Similarly, Prx1-
Cre;Kif3aflox/flox mice display shortened limbs with polydactyly, reduced expression of Gli1 and 
disrupted Gli3 processing. 
Col2a1-Cre;Ift88flox/flox mice display depletion of primary cilia from chondrocytes, 
disorganized columnar structure and decreased responsiveness to Shh treatment (Chang and 
Serra, 2013). They also display upregulation of osteoarthritic markers and thickened cartilage 
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with reduced mechanical properties (Irianto et al., 2014). Col2a1-Cre;Kif3aflox/flox mice display 
post-natal dwarfism due to premature loss of growth plate associated with hedgehog dysfunction 
(Song et al., 2007).  
Deletion of primary cilia within osteoblasts significantly reduces bone formation. Ocn-
Cre;Kif3aflox/flox mice display reduced primary cilia number and length in osteoblasts. They 
exhibit a significant reduction in bone mass and develop osteopenia by 6 weeks of age 
concomitant with reduced hedgehog signaling and impaired osteoblast differentiation (Qiu et al., 
2012). Col1a1-Cre;Kif3aflox/flox mice display reduction of primary cilia in mature osteoblasts and 
osteocytes and have decreased formation of bone in response to cyclic loading (Temiyasathit et 
al., 2012). 
Other mutants that affect the formation of the primary cilium display phenotypes similar 
to knockouts of Ift88 and Kif3a. Talpid3-/- mice display severe polydactyly and shortened long 
bones. E10.5 limb buds show normal Shh expression with anteriorly expanded Grem1 expression 
consistent with and decreased BMP4, Gli1, and Ptch1 expression. Ciliogenesis is disrupted in 
E10.5 limb bud mesenchyme, but not ectoderm (Bangs et al., 2011). Similarly, Prx1-
Cre;Ofd1flox/flox mutants display polydactyly with shortened long bones. In these mice, limb bud 
primary cilia are shortened. They display disrupted hedgehog signaling with normal expression 
of Shh, but decreased Gli1 and Ptch1 expression concomitant with increased Gli3 activator to 
repressor ratio characteristic of disrupted ciliogenesis. At E16.5 in the growth plate there is 
disrupted hedgehog signaling with normal Ihh expression but loss of Gli1 and Ptch1 expression 
along with deficits in proliferation (Bimonte et al., 2011). Mks1del64-323 mice bear a hypomorphic 
allele of the cilia basal body protein Mks1 and display mild polydactyly and defective 
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ciliogenesis resulting in defective Gli3 processing. In the limb bud there is decreased expression 
of Ptch1 and Gli1 that is accompanied by anterior expansion of Grem1 (Cui et al., 2011).  
These studies point to a common phenotype that results from loss of primary cilia within 
the limb bud mesenchyme. Mice with disrupted ciliogenesis in the limb bud mesenchyme display 
shortened limbs with polydactyly. Expression of BMP inhibitor Grem1 is expanded and 
expression of hedgehog responsive genes Ptch1 and Gli1 is reduced. As detailed in the previous 
sections this phenotype represents a concomitant disruption of limb bud outgrowth, patterning, 
and chondrogenesis. Dysfunctional regulation of the growth plates is observed in both limb 
mesenchyme specific conditional knockout mouse models generated with with Prx1-Cre and 
chondrocyte specific mouse knockout models generated with Col2a1-Cre. Analysis of growth 
plate organization in Prx1-Cre and constitutive knockout mouse models is complicated by 
dysfunction present in the limb bud that leads to delay of chondrogenesis. The reduction in bone 
formation observed in osteoblast specific mouse knockout models of primary cilia coincides with 
an observed reduction in hedgehog signaling responsiveness that correlates with the known 
positive role of hedgehog signaling in osteoblast differentiation.  
1.6.4 Primary cilia and planar cell polarity (PCP) effector proteins 
Primary cilia and planar cell polarity (PCP) signaling are two closely related pathways. PCP 
effectors were originally identified in D. melanogaster by their ability to disrupt organized, 
polarized accumulation of F-actin in the imaginal discs characteristic of mutants of the PCP 
pathway (Wallingford, 2012). The identified PCP effector proteins in D. melanogaster include 
fritz (Wdpcp), inturned (Intu), and fuzzy (Fuz). These genes act downstream of the core 
components of PCP signaling. In addition to their role in PCP, these genes are also essential to 
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formation of primary cilia. Recently, Wdpcp, Intu, Fuz have been recognized as members of a 
complex that promotes ciliogenesis (Wallingford, 2012).  
The PCP effectors Fuz and Intu have been demonstrated to play important roles in 
skeletal development. Fuz-/- (Heydeck et al., 2009) and Intu-/- (Zeng et al., 2010) mice display 
polydactyly consistent with disrupted Gli3 processing and limb bud mesenchyme displays 
disrupted ciliogenesis. Additional studies have demonstrated that these proteins play key roles in 
ciliogenesis via control of IFT complexes (Brooks and Wallingford, 2012; Zeng et al., 2010). 
The skeletal phenotype of these mice is similar to all mutants with disrupted Gli3 processing and 
functional loss of Gli3 repressor. 
1.7 WDPCP 
A mutagenesis screen in mice recovered the Cys40 (named due to mutation at cysteine 40) 
mutant, a mouse with severe skeletal defects bearing a null mutation in WD40 domain 
containing planar cell polarity effector protein (Wdpcp). This mutant had a number of hallmarks 
of altered hedgehog signaling including polydactyly and neural tube defects. Further 
investigation revealed alterations in ciliogenesis including impaired formation and architecture in 
multiple tissues (Cui et al., 2013). Wdpcp was first characterized in D. melanogaster as the planar 
cell polarity effector Fritz. These genes function cell autonomously downstream of the core 
planar cell polarity genes to regulate the location and number of wing cell prehair initiation sites 
via polarized accumulation of F-actin (Collier et al., 2005). A study in Xenopus demonstrated a 
role for the Wdpcp homolog Fritz in both ciliogenesis and convergent extension via organization 
of cytoskeletal septins (Kim et al., 2010).  
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The mouse Wdpcp homolog is encoded by 18 exons located at mouse chromosome 
11a3.1 and encodes one known protein isoform (a 722 amino protein). The protein sequence of 
the gene is significantly conserved from flies to humans. In humans Wdpcp mutations are 
associated with ciliopathy syndromes including Bardet-Biedl Syndrome, Alstrom Syndrome, and 
Meckel Gruber Syndrome (Aliferis et al., 2012; Chen et al., 2011; Kim et al., 2010). 
The mouse WdpcpCys40 mutant used in these studies was first described in a 2013 
publication that demonstrated a role for Wdpcp in many developmental processes. In this mutant, 
an A to G substitution at nucleotide 224 of the mRNA resulted in a premature stop codon after 
amino acid 54 (S54X). The conditional Wdpcpflox knockout mouse is also described in this study, 
and is a mouse that bears loxP sites on either side of exon 5. When crossed with a Cre 
recombinase expressing mouse strain, this results in cleavage and recombination at the loxP sites 
that leads to deletion of exon 5 in all Cre recombinase expressing cells (Figure 11). When 
crossed with the constitutive expressing Cre strain CMV-Cre to generate CMV-Cre;Wdpcpflox/flox 
mice, the homozygous inducible knockout mice bear an identical phenotype to the homozygous 
WdpcpCys40/Cys40 mice (Cui et al., 2013). 
WdpcpCys40/Cys40 mice display severe polydactyly (7-9 digits) consistent with observed 
disruption of ciliogenesis and expanded anterior limb bud expression of Grem1 at E10.5. 
Consistent with a loss of responsiveness to upstream regulators of hedgehog, WdpcpCys40/Cys40 
mutants are able to partially rescue both Ptch1-/- and Smo-/- embryos (Cui et al., 2013). 
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Figure 11. Wdpcp Cys40 mutant. 
Wdpcp (A) is composed of 18 exons located on chromosome 11 in Mus musculus that are spliced together to form a 
mature RNA that encodes a 722 amino acid protein with start codon located within exon 2. WdpcpCys40  and 
WdpcpFlox (B) both encode alleles of Wdpcp that result in a mature RNA lacking exon 5. Exon 4 is spliced directly 
to exon 6, resulting in a frameshift mutation that leads to an early stop codon, and results in a severely truncated 
polypeptide 53 amino acids long. Western blot of WdpcpCys40/Cys40- forelimb buds reveals absence of Wdpcp protein 
(C), confirming functional knockout of Wdpcp. 
1.8 SUMMARY 
Degenerative diseases of the skeletal tissues represent a large and growing burden with limited 
effective treatments, none of which are fully capable of fully restoring tissue function. The 
development of highly effective and specific personalized therapies that can exceed the outcomes 
of current therapies by orders of magnitude will depend upon a deep mechanistic understanding 
of the processes that govern skeletal tissue development and homeostasis. Study of the 
development of skeletal tissues in model organisms such as mice has already yielded significant 
insights into the signaling pathways and mechanisms that govern the formation bone and 
cartilage that has been exploited for the development of new therapies for degenerative diseases 
of the skeletal tissues. Forward mutagenesis screens represent a traditional unbiased approach to 
uncovering genes that regulate specific developmental processes.  
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Large-scale mutagenesis screens have been conducted in mice to recover animals bearing 
mutations in genes that affect skeletal development in order dissect the genetic mechanisms 
governing formation and homeostasis of skeletal tissues. In a screen conducted by our 
collaborator, Dr. Cecilia Lo, a novel allele of Wdpcp (Cys40) was identified that when inherited 
in a homozygous manner led to significant skeletal defects. Further investigations revealed that 
the Cys40 allele is a functional deletion of Wdpcp. Inheritance of two copies of Cys40 results in 
the loss of any function of Wdpcp including the absence of transcribed mature Wdpcp RNA and 
Wdpcp protein (Cui et al., 2013). By studying the effects of the loss of Wdpcp at specific time 
points in development and within specific populations of cells that give rise to the skeleton, an 
understanding of the function of when and where Wdpcp functions in skeletal development can 
be gained. Studies using pharmacologic and genetic activators and inhibitors of specific 
pathways previously demonstrated to be involved in skeletal development can elucidate how 
Wdpcp mediates its effects in the larger context of skeletal development. Understanding gained 
from these studies can be exploited to correct pathophysiology associated with Wdpcp loss and 
cell processes that have been demonstrated to be perturbed by Wdpcp loss. 
The studies described below have the goal of determining the specific function of Wdpcp 
within skeletal development. The first aim involves an extensive characterization of the effects of 
loss of Wdpcp on skeletal development using the Cys40 constitutive knockout model along with 
a conditional knockout model. The second aim describes in vitro experiments to study the effects 
of Wdpcp loss and related signaling disruption on the developmental processes of chondrocyte 
and osteoblast differentiation. The third aim describes studies designed to elucidate the specific 
mechanistic role of Wdpcp in the hedgehog signaling pathway and the regulation of Gli 
transcription factor signaling. Together these aims will represent the first description of the role 
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of Wdpcp in both skeletal development and hedgehog signaling and pave the way for future 
studies into the mechanisms of both of these systems. 
 
Specific Aim #1: To characterize the skeletal defects and associated signaling defects present in 
mice lacking functional Wdpcp 
 
Specific Aim #2: To determine the effects and mechanism of Wdpcp loss on chondrogenic and 
osteogenic in vitro differentiation 
 
Specific Aim #3: To determine the mechanism by which hedgehog signaling is disrupted with 
loss of Wdpcp 
 
By completing these aims, a detailed description of the role Wdpcp in skeletal development and 
related signaling will be attained, allowing its role to be placed it in the context of prior and 
future studies as well as to be potentially exploited for therapeutic benefit. Additionally, insights 
gained from specific signaling roles in skeletal development may have far reaching implications 
for other processes that utilize the same signaling pathways such as the development and 
homeostasis of other tissues as well as dysregulation of these signaling pathways in processes 
such as cancer and aging. The following chapters detail the results of experiments designed to 
address each of the above specific aims. 
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2.0  LOSS OF WDPCP DISRUPTS SKELETOGENESIS AT MULTIPLE POINTS IN 
DEVELOPMENT 
2.1 INTRODUCTION 
These studies sought to characterize the skeletal phenotype of the Cys40 mutant, a functional 
null mutant of Wdpcp, to determine when and where in skeletal development Wdpcp functions. 
Specific investigations into signaling pathways known to regulate chondrogenesis and 
osteogenesis revealed that loss of Wdpcp disrupts hedgehog signaling leading to abnormal 
regulation of downstream BMP signaling. Characterization included analyses of Cys40 embryos 
at different time points in skeletal development to determine potential effects of Wdpcp on 
different processes in skeletal development that occur during known time periods. Following 
initial characterization of the Cys40 mutant, the Cre-lox system was used to make tissue and 
developmental stage specific deletions in the progenitors of the appendicular skeleton to 
determine the temporal and spatial requirement for Wdpcp in skeletal development. These 
models allowed for examination of specific phenotype of Wdpcp loss in skeletal progenitor 
populations free from the confounding effects of earlier developmental disruptions and systemic 
Wdpcp loss.  
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2.2 METHODS 
2.2.1 Mouse strains 
The WdpcpCys40/Cys40 mouse (termed Cys40 mutant) and WdpcpFlox/Flox mouse have been 
previously described (Cui et al., 2013). The B6.Cg-Tg(Prrx1-cre)1Cjt/J mouse strain was 
obtained from Jackson Laboratories (Jackson Stock #005584) and is referred to as Prx1-Cre. The 
FVB-Tg(Col2a1-cre/ERT)KA3Smac/J mouse strain was obtained from Jackson Laboratories 
(Jackson stock #006774) and is referred to as Col2a1-CreERT.  
For generation of E10.5 limb buds, E11.5 limb buds, limb bud micromass cultures, and 
mouse embryonic fibroblasts, WdpcpCys40/+ females were crossed with WdpcpCys40/+ males to 
obtain litters containing both WdpcpCys40/Cys40 and Wdpcp+/+ embryos. WdpcpCys40/+ and Wdpcp+/+ 
mice had no differences in terms of skeletal morphology and were grouped and termed control. 
WdpcpCys40/Cys40 embryos were termed Cys40. 
For the generation of conditional mutants, the WdpcpCys40/+ males were crossed to females 
carrying the WdpcpFlox allele and the specific Cre allele to minimize the requirement for Cre 
recombination to achieve complete deletion of Wdpcp (Zhulyn et al., 2014). Prx1-Cre mice were 
crossed with the WdpcpFlox/Flox mice to induce limb bud mesenchyme specific deletion of the 
WdpcpFlox allele (Logan et al., 2002). Female Prx1-cre;WdpcpFlox/+ mice were generated by 
crossing male Prx1-cre mice to female WdpcpFlox/Flox homozygous mice. Female Prx1-
cre;WdpcpFlox/+ mice were crossed to WdpcpCys40/+ males to obtain litters with Prx1-
cre;Wdpcp+/+ and Prx1-cre;WdpcpCys40/Flox mice.  
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Similarly, Col2a1-CreERT mice were crossed with WdpcpFlox/Flox mice for chondrocyte 
specific deletion of Wdpcp (Nakamura et al., 2006). Female Col2a1-CreERT;WdpcpFlox/+ mice 
were generated by crossing male Col2a1-CreERT mice to female WdpcpFlox/Flox homozygous mice. 
Female Col2a1-CreERT;WdpcpFlox/+ mice were crossed to WdpcpCys40/+ males to obtain litters 
with Col2a1-CreERT;Wdpcp+/+ and Col2a1-CreERT;WdpcpCys40/Flox mice. All reported mice are 
from mixed background strains. All histological specimens are shown in comparison to 
littermates and representative of at least 3 biological samples. 
2.2.2 Genotyping and injections for Cre induction 
For genotyping, DNA was extracted from livers of embryos and tail clips of newly weaned mice 
using the REDExtract-N-Amp Tissue PCR Kit (Sigma). Primers used for genotyping are 
included listed in Table 1. The WdpcpCys40 allele was genotyped using Sanger sequencing of a 
150 base pair fragment to identify the relevant A>G base pair change (Figure 12A). The 
WdpcpFlox allele was genotyped using primers to amplify a region containing an inserted flox site 
(424 base pair fragment) or lacking an inserted flox site (262 base pair fragment) that could be 
differentiated with agarose gel electrophoresis. Presence of Cre allele was identified using 
primers specific to Cre that amplified 102 base pair fragment (Figure 12B). In all timed 
pregnancies, plug date was identified as E0.5. Temporal and spatial kinetics of Cre expression 
and recombination in the Col2a1-CreERT mouse line with intraperitoneal 4-OH tamoxifen 
injection has been extensively characterized. Injection of 2 mg 4-OH tamoxifen at E11.5 is 
sufficient to induce strong expression of Cre in all chondrocytes in the cartilage anlagen of the 
limbs (Nakamura et al., 2006). For injections, 4-OH tamoxifen (Sigma) was dissolved in 100% 
ethanol at 100 mg/mL. This solution was further dissolved 1:10 in sterile corn oil followed by 
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gentle heating at 37 °C for 1 hour to ensure uniform dissolution for a final concentration of 10 
mg/mL. For induction of Cre expression, 200 uL of this solution (2 mg) was injected 
intraperitoneally into pregnant dams at 11.5 days post plug. All animal experimentation was 
carried out in according to a protocol approved by the Insitutional Animal Care and Use 
Committee of University of Pittsburgh. 
 
Figure 12. Genotyping of mouse strains. 
The WdpcpCys40 allele is a single base pair change from A to G at the 3’ end of exon 5. WdpcpCys40 allele was 
differentiated from Wdpcp+ by direct Sanger sequencing of a 150 base pair PCR fragment centered on the base pair 
of interest (A). The WdpcpFlox allele was differentiated from the Wdpcp+ allele by amplifying a fragment containing  
(Flox) or lacking (+) a 162 basepair inserted Flox site (B). These fragments were separated with agaorse gel 
electrophoresis. Presence or absence of a Cre allele was determined with presence or absence of a PCR 
amplification product 102 base pairs in length amplified from any inserted Cre. 
 
Table 1. Genotyping PCR primer sequences (5'-3') 
Primer Name Sequence Target 
Cys40-F GATCGATCGCTCAA WdpcpCys40 
Cys40-R AGAGCTGACTGATCGA WdpcpCys40 
Flox-F GCGGAGCTCTACG WdpcpFlox 
Flox-R ATCGATCGATCGC WdpcpFlox 
Cre-F GATCGCTAGCGAAGCGGC Col2a1CreERT; Prx1-Cre 
Cre-R GATCGCGATTAGCGCA Col2a1CreERT; Prx1-Cre 
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2.2.3 Timed matings 
Matings were monitored for copulation plugs each morning. Plugged mice were weighed and 
separated from males with E0.5 considered 1 PM day of plug. Plugged females were re-weighed 
at E10.5 and checked for weight increase of at least 2.5 g to indicate pregnancy. Embryos 
displaying generalized developmental deficiency as evidenced by decreased crown to rump 
length were excluded from analyses. 
2.2.4 Alizarin red and Alcian blue whole mount staining 
Skeletal preparations were made by co-staining embryos with alizarin red S for ossified, calcium 
rich tissue and Alcian blue for cartilage as described previously (Mis et al., 2014). Briefly, 
embryos were scalded in hot tap water, skinned, and their abdominal and thoracic organs 
removed. Livers were saved for genotyping. Embryos were transferred into alcohol before 
staining 24 hours with 40% glacial acetic acid, 60% ethanol, 0.0001% Alcian Blue solution at 
room temperature. Embryos were destained for 24 hours in ethanol before being transferred to a 
solution containing 2% KOH (Sigma) in distilled water with 0.0015% Alizarin Red S (Sigma) 
for 5 hours. Embryos were subsequently destained in 2%KOH in distilled water overnight, 
followed by 1% KOH in 50% glycerol/50% distilled water. Embryos were transferred to 50% 
glycerol/50% distilled water for imaging. All images are representative of 2-6 specimens. For 
limb length quantification, the longest vector along each cartilage element was used. Six limbs 
from six separate animals were used for both mutants and controls. 
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2.2.5 Histology 
Embryos were delivered by caesarean section at determined time point. Internal organs were 
removed and saved for genotyping as described in Section 2.2.2. Skeletons were fixed in 4% 
paraformaldehyde overnight before being dehydrated through an ethanol series. Following 
clearing in xylenes, limbs were transferred to paraffin, embedded, and sectioned at 7 microns. 
Sections were stained with 1% silver nitrate (Sigma) and exposed to 260 nM UVC light for 30 
minutes at room temperature before destaining with 5% sodium thiosulfate (Sigma) for 5 
minutes at room temperature and counter staining with nuclear fast red (Sigma). 
2.2.6 RNA isolation and quantitative real-time polymerase chain reaction (qPCR) 
Total RNA was extracted using TRIzol (Invitrogen) with RNeasy columns (Qiagen) for 
purification and removal of genomic DNA. RNA was quantified spectrophotometrically, and 
cDNA was synthesized from 200 ng of total RNA using Superscript III (Invitrogen) with the 
Oligo(dT) primers per the manufacturer’s protocol. Quantitative real-time PCR was performed 
on Applied BioSystems StepOnePlus with Applied Biosystems SYBR Green PCR mastermix in 
96-well plates. Primers were all used at a concentration of 200 nM. Cycling variables were as 
follows: 95 °C for 10 min, then 40 cycles of 15 second denaturation at 95 °C and 1 minute at 60 
°C. Primer sequences are listed in Table 2. Expression was reported normalized to housekeeping 
gene HPRT due to reported stability of expression of this gene during skeletal development (de 
Kok et al., 2005; Zhai et al., 2013). For the whole limb studies, the mean and standard deviation 
was determined from 3 biological replicates. For micromass culture studies, mean and standard 
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deviation represent 3-4 biological replicates each composed of RNA isolated from 2 
experimental replicates.  
 
2.2.7 Western Blotting 
Forelimb buds from E10.5 embryos were isolated by dissection. Cys40 embryos could be 
differentiated from heterozygous and wild type embryos by concomitant defective ocular 
development in the Cys40 embryos. This association and full penetrance of the Cys40 phenotype 
was confirmed by individually genotyping embryos after forelimb buds had been combined for 
protein isolation. Two to three forelimb buds from separate animals were isolated with a Total 
Protein Extraction Kit (Millipore) supplemented with 5 mM EDTA and 1X Halt Protease and 
Phosphatase Inhibitor Cocktail (Thermo Scientific). Samples were sonicated to homogenized 
lysate, and protein concentration was quantified using BCA assay kit (Pierce) and standardized 
to same concentration using isolation buffer dilution. Western blots were performed as 
previously described (Lozito and Tuan, 2011). Protein samples were subjected to reducing SDS-
PAGE and transferred to low-fluorescence background polyvinyl fluoride (PVDF) membranes 
(Millipore). Membranes were blocked in 3% dried milk in 0.25% Tween-20 in TBS (TBS-T) for 
1 hour at room temperature and probed overnight at 4° C with primary antibody in 1% 
milk/TBS-T. Primary antibodies used are listed in Table 2. After washing with TBS-T, 
membranes were incubated for 1 hour at room temperature with HRP conjugated anti-rabbit 
(Abcam) (1:1000) or poly-HRP conjugated anti-goat antibody (Pierce) (1:2000) in 1% 
milk/TBS-T. Immunoreactive bands were visualized with SuperSignal West Dura Extended 
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Duration Substrate (Thermo Scientific) on a Fotodyne imaging system. Each blot was repeated at 
least in duplicate, and representative blots are presented. 
Table 2. Antibodies 
Antibody 
Target 
Antibody Information Antibody 
concentration 
Application Species 
Gli3 R&D (AF3690) 1:1000 Western Goat 
pSmad1/5/9 Cell Signaling Technology 
(D5B10) 
1:1000 Western Rabbit 
Smad1/5/9 Abcam (ab80255) 1:500 Western Rabbit 
β-actin Santa Cruz (sc-47778) 1:1000 Western Mouse 
 
2.2.8 Statistical analysis 
Two-tailed Student’s T-test with assumption of heteroscedastic populations with significantly 
different variance was used to determine significance for limb lengths and for relative expression 
of qRT-PCR. Results are expressed as mean +/- standard deviation. All histological specimens 
are representative of at least 3 biological replicates. 
2.3 RESULTS 
2.3.1 The Cys40 mutant mouse displays gross skeletal defects 
The E17.5 Cys40 mutant displays drastic skeletal defects including shortened and dysmorphic 
forelimbs and hindlimbs, severe polydactyly (8-9 digits), vertebral ossification and midline 
defects, and facial clefting (Figure 13). The severe polydactyly observed in the Cys40 mutant has 
been observed in mice bearing mutations that affect limb bud patterning. These include 
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mutations in Gli3 and those that affect levels of the effector form of Gli3, the truncated Gli3 
repressor (Osterwalder et al., 2014). Gli2-/-;Gli3-/- mutants have an almost identical phenotype to 
the Cys40 mutant . Midline defects of the vertebral bodies have been described in mutants of 
genes that affect the formation of the primary cilium (Yuan et al., 2015). The fusion of vertebral 
bodies C2-C3 is characteristic of Klippel-Feil Syndrome and has been associated with vertebral 
segmentation defects linked to FGF signaling dysfunction, commonly correlated with disruption 
of primary cilia (Tracy et al., 2004). Because of its relatively more studied development, the 
appendicular skeleton was chosen as an area of focus. In this regard, the investigation was 
broken down to examine specific components of appendicular skeletal development. 
 
Figure 13. Wdpcp null mice display gross skeletal defects 
Alizarin red (bone) and Alcian blue (cartilage) whole mount staining of E17.5 WdpcpCys40/+ (control) (A) and 
WdpcpCys40/Cys40 (Cys40) (B) embryos reveals gross skeletal defects in Cys40 embryos. Appendicular skeletal defects 
include shortened, dysmorphic long bones of forelimb (C, D) and hindlimb (E, F) as well as polydactyly. Axial 
skeletal defects include lumbar vertebral segmentation and ossification defects in Cys40 embryos (H) versus 
controls (G), cervical segmentation defects including fusion of C2-C3 vertebrae in Cys40 embryos (K) versus 
controls (I), and midline sternal defects in Cys40 embryos (L) versus control (J). Black scale bars represent 2 mm in 
all panels.  
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Having made gross characterizations of the specific defects present in E17.5 Cys40 
embryos, examination of different time points in development was undertaken to determine the 
critical period of Wdpcp function for these skeletal defects. At E14.5 Cys40 embryos display 
delayed ossification of the forelimbs (Figure 14) along with significantly shortened cartilage 
anlagen of the long bones of both the forelimbs and hindlimbs (Figure 16) consistent with an 
outgrowth defect in the limb bud. 
 
Figure 14. Skeletal phenotype of E14.5 Cys40 mutant 
Alizarin red and Alcian blue staining of homozygous Cys40 E14.5 embryos reveals delayed ossification, 
polydactyly, shortened appendicular cartilage anlagen, and vertebral defects.  
2.3.2 Prx1-Cre;WdpcpCys40/Flox recapitulates appendicular skeletal phenotype of Cys40 
mutant 
Having determined that the skeletal phenotype of Cys40 mutant mice is present at E14.5, the 
conditional allele of Wdpcp was used to generate a limb mesenchyme specific deletion with the 
Prx1-Cre line. Prx1-Cre expresses Cre recombinase in the forelimb bud mesenchyme at E9.5 
and the hindlimb bud mesenchyme at E10.0. There is also some expression within mesenchymal 
tissues that give rise to the axial and craniofacial skeleton (Logan et al., 2002). Prx1-
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Cre;WdpcpCys40/Flox mice were generated to ensure that minimal Cre activity would required for 
complete loss of Wdpcp from Cre expressing cells.  
Alizarin red/Alcian blue staining of E17.5 Prx1-Cre;WdpcpCys0/Flox embryos (Figure 15) 
reveals that limb mesenchyme specific deletion of Wdpcp recapitulates the appendicular 
phenotype of the Cys40 mutant nearly identically. E17.5 Prx1-Cre;WdpcpCys0/Flox embryos 
display shortened and dysmorphic forelimbs and hindlimbs with severe polydactyly similar to 
Cys40 mutants. As expected due to the spatial and temporal expression pattern of Prx1-Cre, 
E17.5 Prx1-Cre;WdpcpCys0/Flox embryos fail to recapitulate aspects of distal axial skeletal 
phenotype including lumbar vertebral ossification and sternal midline defects. However, fusion 
of the C2-C3 vertebra is recapitulated in E17.5 Prx1-Cre;WdpcpCys0/Flox embryos. 
Figure 15. Wdpcp functions in the limb bud mesenchyme 
Alizarin red and alcian blue whole mount staining of E17.5 Prx1-Cre;WdpcpCys/+ (A) and Prx1CreCys40/flox (B) 
embryos reveals limb mesenchyme specific deletion of Wdpcp results in gross skeletal defects of the appendicular 
skeleton that recapitulate those seen the in Cys40 mutant including forelimb and hindlimb polydactyly with 
shortened and dysmorphic long bones (C-F). Lumbar vertebrae (G, H) and sternae (J, L) display no segmental 
defects or ossification defects observed in Cys40 embryos consistent with spatial expression pattern of Prx1. 
Cervical vertebrae display fusion of C2-C3 as seen in Cys40 embryos consistent with expression of Prx1 in cephalic 
mesoderm (I, K). Black scale bars represent 2 mm in all panels.  
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2.3.3 Disruption of limb bud exit to chondrogenesis with Wdpcp deficiency 
Onset of chondrogenesis is delayed in the Cys40 embryos as evidenced by expression of 
chondrogenic marker genes (Figure 17) at E11.5. Chondrogenesis initiates in the limb bud at 
~E11.0 and is associated with upregulation of expression of genes that make up the characteristic 
matrix of chondrocytes. Lower expression in the Cys40  mutants of these is consistent with the 
observed phenotype at E14.5 and E17.5 of the Cys40 mutant. The E17.5 at E14.5 mutants both 
display formation of bone and cartilage indicating that Wdpcp is not absolutely required for 
chondrogenesis or osteogenesis. However, the decreased expression of chondrogenic markers at 
E11.5 indicates that Wdpcp does play significant role in the initiation of chondrogenesis.  
 
Figure 16. Cys40 embryos have smaller appendicular cartilage anlagen 
Alcian blue and alizarin red staining of E14.5 embryos reveals that cartilage anlagen of the forelimb skeletal 
elements, including the radius, ulna (A, G), humerus (B, H), and scapula (C, I), are significantly shorter in the Cys40 
embryos compared to controls (M). Cartilage anlagen of the hindlimb skeletal elements including the fibula, tibia 
(D, J), and femur (E, K) are significantly shortened in Cys40 embryos compared to controls (M). No significant 
difference was observed in the size of the pelvis skeletal elements (F, L) of Cys40 embryos compared to controls 
(M). All scale bars are 2 mm. Error bars represent one standard deviation. Cys40 is compared to matched control 
with * for p<0.05, ** for p<0.01, *** for p<0.001. 
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Figure 17. Loss of Wdpcp results in delayed chondrogenesis in the limb bud 
Expression of chondrogenic marker genes Col9a1 (A) and Col2a1 (B) is significantly decreased in Cys40 E11.5 
forelimb buds versus controls. Expression of chondrogenic marker gene Acan (C) is at a lower level than Col2a1 
and Col9a1 and is not significantly different in Cys40 E11.5 forelimb buds versus controls. Error bars represent one 
standard deviation. Cys40 is compared to matched control with * for p<0.05, ** for p<0.01, *** for p<0.001. 
 
2.3.4 Disruption of limb bud signaling with Wdpcp deficiency 
Having observed that Wdpcp deficiency affects the onset of chondrogenesis, a mechanism for the 
role of Wdpcp in chondrogenesis was sought. Previous studies have shown that BMP signaling is 
a key regulator of chondrogenesis. Treatment of limb bud mesenchyme with Bmp2 results in 
accelerated chondrogenesis (Denker et al., 1999). Limb mesenchyme specific knockout of 
Bmpr1a results in failure of chondrogenesis (Ovchinnikov et al., 2006). Disruption of the 
intracellular signal transducers of BMP signaling Smad1/5/9 also results in complete disruption 
of chondrogenesis (Pignatti et al., 2014). Similarly, overexpression of BMP inhibitor Grem1 in 
limb mesenchyme results in delayed chondrogenesis and polydactyly similar to the phenotype 
observed in the Cys40 mutant (Norrie et al., 2014). Deletion of Bmp4 in limb mesenchyme also 
disrupts chondrogenesis and results in polydactyly (Selever et al., 2004). BMP signaling levels in 
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the limb bud rise at E10.5 to initiate chondrogenesis (Pignatti et al., 2014). Limb buds isolated 
from E10.5 Cys40 embryos displayed decreased activation of the BMP signaling pathway. 
Phosphorylation of Smad1/5/9 was reduced in Cys40 limb buds (Figure 18D), indicating 
decreased transduction of BMP signal. Additionally, expression of the BMP target gene Msx2 
was significantly reduced in Cys40 mutants (p<0.05) (Figure 18B). Accordingly, expression of 
the BMP inhibitor Grem1 was significantly increased (p<0.05) in the Cys40 mutants (Figure 
18A). Interestingly, an increase in expression of Bmp4 (p<0.05) was also observed in the Cys40 
mutants. This increase has been observed in other mutants with increased expression of Grem1 
in the limb mesenchyme and is believed to be reactionary compensation(Norrie et al., 2014).  
The expression of Grem1 in the limb bud mesenchyme is specifically regulated by the 
hedgehog pathway (Pignatti et al., 2014). Deletion of Shh in the limb bud results in loss of 
Grem1 expression (Benazet et al., 2009). Shh is secreted from the ZPA and functions primarily 
by regulating the levels of Gli transcription factors. The level of Gli3 and specifically the 
repressor form of Gli3 (Gli3R) is directly regulated by hedgehog pathway activation. Increasing 
activation of the pathway results in decreasing levels of Gli3R. Gli3R direct regulates the 
expression of Grem1. Gli3R has been shown to bind a cis acting Grem1 enhancer, GRE1 
(Zuniga et al., 2012). Thus, due to the observed elevation of Grem1 expression, expression of 
Gli3 and, specifically, levels of Gli3R was determined. The Cys40 mutant displayed decreased 
levels of Gli3R in the limb bud (Figure 18D).  The decreased expression of Shh (p<0.05) is 
consistent with the observed deficit in limb outgrowth (Zhulyn et al., 2014). This is consistent 
with previous reports that Wdpcp is a key component and necessary for formation of the primary 
cilium (Cui et al., 2013), an organelle necessary for normal hedgehog signal transduction and 
formation of Gli3R (Goetz and Anderson, 2010).  
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Figure 18. Loss of Wdpcp disrupts Gli3 repressor formation and BMP signaling in the limb bud 
Expression of BMP inhibitor Grem1 (A) is significantly increased in Cys40 E10.5 forelimb buds versus controls. 
Expression of BMP pathway target Msx2 (B) is significantly decreased in Cys40 E10.5 forelimb buds versus 
controls. Expression of Bmp4 (C) is not significantly changed in Cys40 E10.5 forelimb buds versus controls. 
Western blot of E10.5 forelimb buds reveals loss of Wdpcp correlates with decreased Gli3R and increased Gli3FL 
as well as decreased pSMAD1/5/9 (D). Error bars represent one standard deviation. Cys40 is compared to matched 
control with * for p<0.05, ** for p<0.01, *** for p<0.001. 
2.3.5 Chondrocyte specific deletion of Wdpcp disrupts osteogenesis 
Having determined a specific role for Wdpcp in the limb bud, further studies sought to determine 
whether the observed skeletal defects in the Cys40 mice were a propagation of the deficits 
accumulated during limb bud signaling or whether they were compounded with deficits acquired 
later in skeletal development. To rule out the effects of Wdpcp in the limb bud and on 
chondrogenesis in the observed skeletal dysmorphogenesis, mice bearing a chondrocyte specific 
deletion of Wdpcp were generated by crossing mice carrying a tamoxifen-inducible, chondrocyte 
specific Cre recombinase allele (Col2a1-CreERT). In this mouse, an inactive form of Cre 
recombinase is expressed from the collagen 2 (Col2a1) promoter, a gene whose expression is 
restricted to chondrocytes (Nakamura et al., 2006). Where it is expressed, the inactive Cre 
recombinase can be activated with administration of 4-OH tamoxifen. Thus, injection of 4-OH 
tamoxifen into pregnant mothers at a specific time point in development can induce activation of 
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Cre recombinase activity in all chondrocytes at a specific time point. Previous characterization of 
this mouse line demonstrated that injection of 2 mg of 4-OH tamoxifen at E11.5 was sufficient to 
induce Cre recombinase activity in all chondrocytes and chondrocyte descendants of the 
developing limbs (Nakamura et al., 2006). 
 The Col2a1-CreERT mice were bred to mice carrying a floxed allele of Wdpcp. This allele 
has LoxP sites inserted on either side of exon 5 of Wdpcp (Figure 12). Loxp sites are the targets 
of Cre recombinase and in cells with active Cre recombinase, two single LoxP sites are 
recombined and the intervening short segment of DNA excised and degraded (Gu et al., 1993). 
In order to ensure that efficient deletion of Wdpcp was achieved, mice carrying the Col2aCreERT 
a single floxed allele along with the null Cys40 allele were generated (Col2a1-
CreERT;WdpcpCys40/Flox) to minimize the required level of Cre activity necessary for completed 
deletion of functional Wdpcp. 
 Mice bearing chondrocyte specific deletion of Wdpcp appeared grossly normal at E17.5, 
indicating that limb length deficits and polydactyly were due primarily to dysfunction resulting 
from Wdpcp loss in the limb bud prior to chondrogenesis. On closer examination of the growth 
plate structure and long bones at E14.5, there was a slight deficit in osteogenesis in the Col2a1-
CreERT;WdpcpCys40/Flox mice as evidenced by decreased von Kossa staining for bone at primary 
center of ossification in the humerus (Figure 19).  
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Figure 19. Skeletal phenotype of chondrocyte specific deletion of Wdpcp. 
Alizarin red Alcian blue staining of E17.5 Col2a1-CreERT;Wdpcp+/flox (A,C) littermate controls and Col2a1-
CreERT;WdpcpCys40/flox mice (B,D) injected with tamoxifen at E11.5 display no gross skeletal tissue differences. 
Sections of E14.5 humerus stained with von Kossa for bone (black) show that Col2a1-CreERT;WdpcpCys40/flox mice 
have decreased trabecular bone at the primary center of ossification at this time point. 
 
2.4 DISCUSSION 
The ability of Prx1-Cre;WdpcpCys40/Flox mice to recapitulate the appendicular skeletal phenotype 
of the WdpcpCys40/Cys40 mouse indicates that Wdpcp functions during appendicular skeletal 
development in the limb mesenchyme and/or limb mesenchymal progenitors. The failure of the 
Col2a1-CreERT;WdpcpCys40/Flox mice induced with tamoxifen injection at E11.5 to recapitulate the 
patterning and outgrowth phenotype indicates that Wdpcp exerts its influence over these 
processes prior to onset of chondrogenesis. The severe polydactyly observed in the 
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WdpcpCys40/Cys40 and Prx1-Cre;WdpcpCys40/Flox mice is characteristic of mice carrying mutations in 
genes that disrupted ciliogenesis (Heydeck et al., 2009; Zeng et al., 2010). Disruption of the 
primary cilium alters post-translational processing of the hedgehog target transcription factors 
Gli2 and Gli3 to disrupt hedgehog signal transduction. In the Cys40 mice, processing of full-
length Gli3 to truncated Gli3 repressor is disrupted, resulting in a functional loss of Gli3 
repressor. The increase in expression of the BMP inhibitor Grem1 correlates with the observed 
decrease in activation of the BMP signaling pathway as measured by phosphorylated Smad1/5/9 
in the E10.5 limb bud and decreased expression of BMP target gene Msx2 in the E10.5 limb bud. 
BMP signaling is necessary to trigger exit of mesenchymal limb bud progenitors from 
proliferation to chondrogenic differentiation (Lopez-Rios et al., 2012). Mice lacking Wdpcp 
display decreased expression of chondrogenic markers Col2a1, Acan, and Col9a1 and increased 
expression of the proliferative marker Ccnd1 at E11.5 and E12.5 in the forelimb buds.. 
Given that there is an observed deficit in the Gli3R that is correlated with increased 
Grem1 expression and decreased BMP signaling, it would be informative to determine the 
effects of different double mutants on the phenotype of these mice. Mice overexpressing the 
truncated repressor form of Gli3 (Gli3R701) have deficient limb bud outgrowth with oligodactyly 
(Cao et al., 2013). WdpcpCys40/Cys40-;Gli3R701/701 mice could be hypothesized to display an 
intermediate phenotype between the polydactyly observed in the Cys40 mutant and the 
oligodactyly observed in the Gli3R701 mutant that is dependent on the dosage of Gli3R received 
by limb mesenchyme. An inducible model of Gli3R over expression could determine temporal 
specificity for this requirement. 
The underlying phenotype of disrupted exit to chondrogenesis in the Cys40 mice is 
associated with increased expression of BMP inhibitor Grem1 and decreased BMP signaling 
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pathway activation. Prx1-Cre;RosaGrem1 mice are engineered to overexpress Grem1 in the limb 
bud mesenchyme, similar to the overexpression of Grem1 observed in the Cys40 mutant. These 
mice display a phenotype very similar to the Cys40 mutant mice including polydactyly and 
shortened and dysmorphic long bones (Norrie et al., 2014). Conversely, mice with a targeted 
deletion of the Grem1 display oligodactyly(Benazet et al., 2009). WdpcpCys40/Cys40;Grem1-/- mice 
could be hypothesized to display a phenotype that resembles the Grem1-/- mice, confirming 
Wdpcp controls the process of chondrogenesis via modulation of hedgehog signaling input on 
BMP signaling.  
Osteoblast specific deletion of Wdpcp using Osx-Cre or Col1a1-Cre could be 
investigated. Studies on the role of primary cilia deletion with these Cre strains demonstrate 
similar findings including decreased bone formation and decreased formation spongy bone(Qiu 
et al., 2012; Temiyasathit et al., 2012). The effects of deletion of Wdpcp on adult cartilage 
homeostasis should also be examined. Studies using the non-inducible Col2a1-Cre line have 
shown differences in cartilage mechanical properties and early development of osteoarthritis 
symptoms (Irianto et al., 2014). Determining the effect of induction of primary cilia loss after the 
developmental period may yield interesting insights into the function of primary cilia in adult 
cartilage homeostasis independent of developmental effects. 
2.5 CONCLUSION 
These studies demonstrate that Wdpcp acts within the limb bud mesenchyme to facilitate 
chondrogenesis. The ability of the Prx1-Cre;WdpcpCys40/flox mice to recapitulate the appendicular 
skeletal phenotype of the WdpcpCys40/Cys40 mice demonstrates that the observed phenotype is due 
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to loss of Wdpcp from the limb bud mesenchyme. The observed appendicular skeletal phenotype 
does not depend on loss of Wdpcp function from any adjacent tissues such as the limb ectoderm 
or from tissues that may secrete or regulate circulating factors. The lack of outgrowth and 
patterning defects observed in the appendicular skeleton of the Col2a1-CreERT;WdpcpCys40/flox 
mice demonstrate that Wdpcp affects these processes prior to chondrocyte differentiation at 
E12.0 when the injection of tamoxifen has induced Cre recombinase activity. It also suggests that 
disruption of cilia due to Wdpcp loss does not play a major role in growth plate organization. 
Examining the phenotype of these mice at later points for premature closure of the growth plate 
as was observed in Col2a1-Cre;Kif3aflox/flox mice will be informative. The decreased trabecular 
bone staining at E14.5 in the Col2a1-CreERT;Wdpcpcys40/flox mice points to disrupted bone 
formation and possibly osteoblast differentiation in these mice. These findings are consistent 
decreased hedgehog signaling responsiveness due to disrupted ciliogenesis.  
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3.0  WDPCP IS NECESSARY FOR NORMAL CHONDROGENESIS AND 
OSTEOGENESIS 
3.1 INTRODUCTION 
Having demonstrated a specific set of signaling deficits associated dysfunctional hedgehog 
signaling and associated skeletal developmental processes, in vitro approaches were utilized to 
further investigate the effects of alterations in cell signaling on these skeletal development 
processes. Utilizing cells derived from Cys40 mutants and littermate controls, limb bud 
micromass culture was used to assay chondrogenesis and two-dimensional osteogenesis with 
mouse embryonic fibroblasts (MEFs) was utilized to assay osteogenesis. 
3.2 METHODS 
3.2.1 In vitro chondrogenic differentiation: limb bud micromass 
WdpcpCys40/+ male and female mice were crossed and pregnant females sacrificed at E11.5 to 
generate litters with Cys40 mutants and littermate controls. E11.5 Homozygous Cys40 mutants 
could be visually differentiated from embryos carrying at least one functional copy of Wdpcp by 
disrupted eye formation. However, WdpcpCys40/+ and Wdpcp+/+ mice could not be differentiated 
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within the time period required to pool limbs and establish cultures. Given that no phenotypic or 
molecular differences were observed between heterozygous and wild-type embryos, these limbs 
were pooled to create control cultures. Micromass cultures were prepared as previously 
described (Bruce et al., 2010; DeLise et al., 2000; Denker et al., 1999; Stanton et al., 2004). 
Dissected limbs were dissociated in 1 unit/mL dispase (Stem Cell Technologies) for 1.5 h at 37 
°C. Digested limbs were pipetted up and down with 200 uL pipette to break up cells before being 
diluted in 10 mL 2:3 DMEM/F-12 medium containing 10% MSC qualified FBS (Invitrogen) 
(growth medium) to neutralize trypsin. This suspension was passed through a 40 um filter and 
pelleted at 1,200g. After re-suspension in 2:3 DMEM/F-12 medium, cell number was counted 
using hematocytometer. Cells were then divided into experimental groups, pelleted and 
resuspended in 2:3 DMEM/F-12 supplemented with either DMSO or appropriate 
pharmacological agent dissolved in DMSO. Cells were diluted to 10 million cell/mL and spotted 
in 10 uL droplets on Nunc 24 –well culture dishes. Cells were allowed to adhere for 1.5h in a cell 
incubator with humidified atmosphere containing 5% CO2. After two hours wells were flood 
with growth medium containing appropriate pharmacological agent. Cultures were harvested 
after 3 days.  
3.2.2 Generation of mouse embryonic fibroblasts (MEFs) 
WdpcpCys40/+ females were bred to WdpcpCys40/+ males and pregnant females were sacrificed at 
E13.5. Embryos were immediately delivered by Caesarean section into pre-warmed DMEM. 
Livers were removed and saved for genotyping (Figure 12). Internal organs including digestive 
tract, kidneys, diaphragm, heart, lungs, spleen, bladder, and aorta were removed. Single embryos 
were decapitated and remaining skeletal and dermal elements from each embryo were placed 
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individually in 1 mL 0.5% Trypsin EDTA and minced with sterilized razor blades in 10 cm cell 
culture dish. Minced embryos were incubated in tissue culture incubator at 37 C for 5 minutes. 
Minced and digested embryos were diluted in 10 mL cell culture medium composed of DMEM 
supplemented with 10% MSC qualified FBS (Gibco) with 1X Penicillin/Streptomycin/Fungizone 
(Gibco) growth medium to inactivate trypsin. MEFs were pipetted up and down to break up 
remaining tissue before spinning at 1000g to pellet in 15 mL Vulcan tube. MEFs were 
resuspended in growth medium and plated on T75 at what was considered passage 0. MEFs were 
expanded two days with growth medium changed each day. MEFs were passaged on day 2 and 
split to two T150 (1:4). MEFs were grown to 90% confluence, passaged, and frozen in 
cryoprotective freezing medium (Lonza) for storage in liquid nitrogen. All experiments using 
MEFs were conducted at passage 3 or 4.  
3.2.3 In vitro osteogenic differentiation 
It was reported in that MEFs were capable of differentiation into adipogenic, osteogenic, and 
chondrogenic lineages (Saeed et al., 2012). Following expansion, MEFs were seeded at 70% 
confluence (100,000 cells/cm2) in growth medium for two days before changing to standard 
osteogenic medium containing 1 mM β-glycerolphosphate, 100 nM ascorbic acid, and 20 ng/mL 
rBMP2 (Peprotech) supplemented with 10 nM smooth agonist (SAG, Calbiochem). Osteogenic 
medium was changed every 4 days. Alkaline phosphatase activity was measured with para-
nitrophenyl phosphate assay (Sigma) at day 4 of osteogenic differentiation. Eight independent 
biological replicates were used for quantification. Statistics were performed as described in 
Section 2.2.8. 
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3.2.4 Histology 
3.2.4.1 Alcian Blue staining 
Alcian blue staining was used to assay chondrogenesis of limb bud micromass cultures. Cultures 
were rinsed with PBS and fixed in 4% paraformaldehyde at room temperature for 15 minutes. 
Following PBS rinse, cultures were stained overnight at 4C with 1% Alcian blue stain solution at 
pH 1.0 (EK Industries). Cultures were rinsed with PBS 3x and imaged on upright Olympus 
SZX16 microscope. A representative image of 3 to 4 independent biological replicates is shown 
for Alcian Blue staining. 
3.2.4.2 Alizarin Red staining 
Alizarin red staining was used to assay calcium matrix deposition of osteogenic cultures. MEFs 
were fixed in 70% ethanol before being stained for 15 minutes with 2% alizarin red solution at 
pH 4.2 (Rowley Biochemical Institute). For quantification 1 mL of cetylpyridinium chloride was 
used per 6 well plate well to solubilize dye. DNA was isolated from an analogous 6 well plate 
well with 1 mL of 0.5% Triton X-100 in distilled water and quantified using Quant-iT PicoGreen 
dsDNA Assay Kit (Life Technologies). Soluble alizarin red was quantified spectroscopically 
(A580). Six independent biologic replicates were used for quantification. Statistics were 
performed as described in Section 2.2.8. 
3.2.5 RNA isolation and qPCR 
RNA isolation, reverse transcription, and qPCR assays were performed as described in section 
2.2.6, with 3 experimental replicates each containing two pooled biological replicates to obtain 
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sufficient RNA concentration. Relative expression was determined using validated primers 
(Appendix A) and the ΔΔCT method, with expression reported relative to endogenous control 
hypoxanthine-guanine phosphoribosyltransferase (Hprt). Statistics were performed as described 
in Section 2.2.8. 
3.3 RESULTS 
3.3.1 Micromasses lacking functional Wdpcp do not respond to Smo antagonism with 
enhanced chondrogenesis  
To further investigate the role of Wdpcp in chondrogenesis, we utilized in vitro limb bud 
micromass cultures (Bruce et al., 2010; DeLise et al., 2000; Denker et al., 1999) from Cys40 and 
control limb buds (Figure 20A-D). Cys40 cultures displayed decreased Alcian Blue staining 
(Figure 20A,C) and Col2a1 expression (Figure 20G) compared to wild type controls. Ptch1 and 
Gli1 are direct transcriptional targets of Gli3 and increased expression is associated with 
activation of the hedgehog pathway (Briscoe and Therond, 2013; Goodrich et al., 1996; Hui and 
Angers, 2011). As expected with decreased formation of the truncated repressor form of Gli3, 
expression of Ptch1 and Gli1 was significantly increased in Cys40 cultures (Figure 20E,F). As in 
the Cys40 limb buds, the observed decrease in chondrogenesis was correlated with an increase in 
the expression of Grem1 (Figure 20H).   
Having observed that the deficient formation of hedgehog pathway transcription factor 
Gli3 repressor in the Cys40 limb buds was associated with increased Grem1 expression and 
concomitant decrease in chondrogenic differentiation, we hypothesized that silencing of the 
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hedgehog pathway could decrease Grem1 expression and rescue chondrogenesis. Cyclopamine is 
a hedgehog pathway antagonist that functions by inhibiting the activity of Smo (Chen et al., 
2002). Alcian Blue staining (Figure 20B,D) and Col2a1 expression levels (Figure 20E) revealed 
that treatment of both control and Cys40 cultures with cyclopamine had no effect on 
chondrogenesis. While we did observe a significant decrease in the expression of Gli1 (Figure 
20E) with cyclopamine treatment as expected (Chen et al., 2002), Ptch1 and Grem1 expression 
were not significantly affected in either Cys40 or control cultures (Figure 20F,H). Previous 
studies have noted that cyclopamine has minimal effect on chondrogenesis of wild type limb bud 
cultures (Bruce et al., 2010). The lack of response to cyclopamine observed in the Cys40 cultures 
is consistent with the disruption of hedgehog signaling below the level of Smo at the primary 
cilium (Huangfu and Anderson, 2005). 
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Figure 20. In vitro chondrogenesis of micromass culture of Wdpcp null limb bud cells cannot be rescued with 
Smo antagonism 
Alcian Blue staining of control (A, B) and Cys40 (C, D) E11.5 limb bud micromass cultures treated with carrier 
control DMSO or 5 µM cyclopamine (CYC). Expression of hedgehog pathway reporter Gli1 (E) and Ptch1 (F) in 
Cys40 cultures is not significantly affected by treatment with 5 µM cyclopamine. Expression of chondrogenic 
marker gene Col2a1 (G) in Cys40 cultures is not significantly affected by treatment with 5 µM cyclopamine. 
Expression of BMP antagonist Grem1 (H) is not significantly affected in Cys40 cultures treated with 5 µM 
cyclopamine. Error bars represent one standard deviation. Effect of drug treatment within a genotype is calculated 
using Student’s t-test with * for p<0.05, ** for p<0.01, *** for p<0.001. 
3.3.2 Direct Gli antagonism rescues chondrogenic deficit in Wdpcp deficient micromasses 
Having observed that inhibition of hedgehog at the level of Smo was unable to affect 
chondrogenesis or associated signaling, we used a direct inhibitor of the downstream 
transcription factor Gli known as GANT61 (Lauth et al., 2007). It was observed that 
chondrogenesis could be rescued in Cys40 MEFs by inhibition of hedgehog pathway at the level 
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of the Gli transcription factors with direct inhibition of Gli-DNA interactions with Gli antagonist 
GANT 61. Treatment of Cys40 limb bud micromass cultures with 50 uM GANT61 results in 
increased Alcian blue staining of Cys40 and control cultures (Figure 21A-D) as well as 
significantly decreased expression (p<0.05) of hedgehog pathway reporter Ptch1. These findings 
coincide with significantly decreased expression of BMP antagonist Grem1 (Figure 21H) and 
significantly increased expression of chondrogenic marker gene Col2a1 (Figure 21G). 
 
Figure 21. In vitro chondrogenesis in micromass cultures of Wdpcp null limb buds can be rescued with Gli 
antagonist treatment 
Alcian blue staining of limb bud micromass cultures derived from control embryos (A-B) and Cys40 embryos (C-D) 
shows treatment with Gli inhibitor GANT61 increases Alcian blue staining of Cys40 cultures (D) versus DMSO 
treated control cultures (C). No significant change is observed in expression of hedgehog pathway target Gli1 with 
GANT61 treatment in either control of Cys40 cultures (E). Increase in Alcian blue staining of GANT61 treated 
Cys40 cultures corresponds with decrease in expression of hedgehog pathway target Ptch1 (F), increase in 
expression of chondrogenic marker Col2a1 (G), and decrease in expression of BMP inhibitor Grem1 (H). Error bars 
represent one standard deviation. Effect of drug treatment within a genotype is calculated using Student’s t-test with 
* for p<0.05, ** for p<0.01, *** for p<0.001. 
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3.3.3 Cys40 mutant MEFs display deficient in vitro hedgehog stimulated osteogenesis 
Cys40 mutant MEFs display decreased osteogenic differentiation compared to control. 
Deposition of calcified matrix as assayed by alizarin red staining at 20 days of osteogenic 
medium culture is significantly reduced in Cys40 MEFs versus controls (Figure 22A-C). 
Alkaline phosphatase activity at 4 days of osteogenic medium culture, necessary for generating 
the phosphate component of hydroxyapatite, is significantly decreased in Cys40 MEFs versus 
controls (Figure 22C). Analysis of gene expression after 20 days of culture in osteogenic 
medium reveals decreased expression of hedgehog pathway reporter genes Gli1 and Ptch1 in 
Cys40 MEFs versus controls (Figure 22D). Expression of early osteogenic marker Runx2 is not 
significantly different between Cys40 MEFs and controls, while expression of late osteogenic 
markers Osx, Col1a1, and Ocn is significantly decreased in Cys40 MEFs versus controls (Figure 
22E). 
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Figure 22. Cys40 MEFs display decreased osteogenesis 
Alizarin red staining for calcified matrix is significantly decreased in Cys40 MEFs at day 20 compared to control 
MEFs (A, B). Alkaline phosphatase activity at day 4 is significantly decreased in Cys40 MEFs at day 4 compared to 
control MEFs (C). Hedgehog pathway activity as assayed by expression of hedgehog reporter genes Gli1 and Ptch1 
is significantly decreased in Cys40 MEFs compared to controls at day 20 of osteogenic medium culture (D). 
Expression of early osteogenic differentiation marker Runx2 is not significantly different between Cys40 MEFs and 
control MEFs at day 20 of osteogenic medium culture. Expression of mature osteogenic markers Osx, Col1a1, and 
Ocn is significantly decreased in Cys40 MEFs compared to controls at day 20 of osteogenic medium culture. Error 
bars represent one standard deviation. Effect of drug treatment within a genotype is calculated using Student’s t-test 
with * for p<0.05, ** for p<0.01, *** for p<0.001. 
 
3.4 DISCUSSION 
Cys40 cultures display increased activation of the hedgehog reporter genes Gli1 and Ptch1 in 
agreement with the observed loss of Gli3R in the limb buds. Cys40 cultures also display 
decreased chondrogenesis versus control as assayed by Alcian blue stained nodule formation and 
expression of chondrogenic marker Col2a1 in agreement with observed chondrogenic delay in 
E10.5 Cys40 limb buds. The upregulation of early chondrogenic marker Cdh2 in both Cys40 and 
cyclopamine treated MEFs maybe due to off target effects of high doses of cyclopamine used 
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(Meyers-Needham et al., 2012) or could signal that upregulation of Cdh2 is independent of 
hedgehog signaling in this culture system. GANT61 is able to suppress hedgehog signaling and 
mimic the effect of Gli3R in the Cys40 MEFs due to its function as a direct Gli-DNA interaction 
inhibitor (Lauth et al., 2007). By inhibiting all Gli-DNA interactions, the balance of Gli activator 
to repressor becomes irrelevant, and GANT61 serves as a potent inhibitor of hedgehog signaling. 
The inhibition of hedgehog signaling by complete disruption of all activating Gli-DNA 
interactions with GANT61 treatment allows Grem1 expression levels to decrease, facilitating the 
activation of BMP signaling to rescue of chondrogenesis as measured by Alcian blue staining 
and expression of chondrogenic marker gene Col2a1. 
Other studies utilizing the limb bud micromass model have noted that activation of the 
hedgehog pathway via Smo agonist purmorphamine treatment suppresses chondrogenic 
differentiation (Lewandowski et al., 2014). They have similarly noted increased expression 
hedgehog activated genes Gli1  and Ptch1  coincides with increased expression of Grem1 as well 
as suppression of the BMP target gene Msx2 (Lewandowski et al., 2014). Limb micromass 
cultures from Prx1-Cre;Ptch1flox/flox mice with constitutively activated hedgehog signaling in 
limb mesenchyme display increased expression of Gli1 and Ptch1 but also show increased 
expression of chondrogenic transcription factors Sox5, Sox6, and Sox9. However, expression of 
Col2a1 is decreased in Prx1-Cre;Ptch1flox/flox hindlimb cultures and Alcian blue staining is 
significantly reduced in all Prx1-Cre;Ptch1flox/flox cultures. It is also noted that exogenous Shh 
application has no significant detrimental effect on Alcian blue staining or Col2a1 expression 
(Bruce et al., 2010). This observed difference between the two studies may be due to the 
increased levels of Ptch1 that effectively inhibit Shh, but cannot inhibit Smo activation caused by 
purmorphamine. 
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The significantly decreased deposition of alizarin red staining calcified matrix, decreased 
alkaline phosphatase activity, and reduced expression of late osteogenic marker genes Ocn, 
Col1a1, and Osx all indicate that osteogenesis in the Cys40 MEFs is impaired (Figure 22). The 
failure to see a significant difference expression of Runx2 is likely due to the fact that this is an 
early marker of osteogenic differentiation. The decreased osteogenesis observed in response of 
Cys40 MEFs to hedgehog activity correlates with the decreased hedgehog responsiveness that is 
reported in chapter 4. Hedgehog pathway activation is essential to osteogenesis and the 
formation of bone as documented in numerous studies. Ihh-/- mice and mice with constitutive 
inactivation of hedgehog signaling due to Smo-/- display defective bone formation (Long, 2012; 
St-Jacques et al., 1999). Additionally, the osteogenesis deficit in Cys40 MEFs and decreased 
bone formation observed in E14.5 Col2a1-CreERT;Wdpcpflox/Cys40 mice versus controls agree with 
reports of other mutants that affect the formation of primary cilia (Qiu et al., 2012; Song et al., 
2007; Temiyasathit et al., 2012). 
3.5 CONCLUSION 
The ability of direct Gli inhibitor GANT61, but not Smo inhibitor, cyclopamine to rescue the 
deficit in chondrogenesis observed in Cys40 forelimb bud micromasses demonstrates that 
hedgehog signaling is disrupted in Cys40 mice below the level of Smo. Furthermore, the ability 
of direct Gli inhibition to decrease the expression of Grem1 concomitant with the increase in 
chondrogenesis as assayed by Alcian blue staining confirms that the observed increased levels of 
Grem1 in the E10.5 Cys40 forelimbs is responsive to hedgehog signaling. Loss of Gli3 repressor 
and suppressive hedgehog effects on transcription Grem1 disrupts chondrogenesis early in limb 
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skeletogenesis (Figure 20). Conversely, failure to fully activate hedgehog pathway targets 
disrupts osteogenesis later in limb skeletogenesis as evidenced by decreased expression of 
hedgehog target genes and decreased osteogenic differentiation as measured by expression of 
mature osteoblast markers, calcified matrix deposition and alkaline phosphatase activity in Cys40 
MEFs (Figure 22). These findings underlie the importance utilizing stage specific models and 
assays to dissect the specific disruption of signaling pathways. The phenotype of Cys40 mutant 
results not from complete silencing or complete hyperactivation of a signaling pathway, but from 
loss of responsiveness. 
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Figure 23. Effects of Wdpcp loss on chondrogenesis are mediated by hedgehog control of BMP signaling.  
In the normal limb bud (A), limb bud outgrowth is initiated by formation of the apical ectodermal ride (AER). The 
AER secretes FGFs (red) that support the expression of Shh (green) from the zone of polarizing activity (ZPA) at the 
posterior aspect of the limb bud. Shh from the ZPA drives expression of both BMPs (yellow) and BMP inhibitor, 
Grem1 (blue), in the limb mesenchyme. Grem1 limits the activity of BMPs to suppress the BMP signaling pathway 
and delay chondrogenesis to allow proliferation and limb bud outgrowth. When the limb bud reaches a critical size, 
Shh (green) signal from the ZPA no longer reaches the anterior aspect of the limb bud mesenchyme, allowing 
accumulation of the repressive form of the hedgehog transcription factor Gli3R (brown). Gli3R serves to inhibit the 
expression of Grem1 in the limb bud mesenchyme, allowing BMP pathway activity to rise and trigger 
chondrogenesis. In the Cys40 mutants (B), Gli3R levels are decreased, leading to increased Grem1 expression, 
decreased BMP activity, and inhibited chondrogenesis. (Adapted from Pignatti et al., 2014 with permission) 
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4.0  WDPCP AFFECTS HEDGEHOG SIGNALING AT THE PRIMARY CILIUM BY 
ALTERING GLI PHOSPHORYLATION 
4.1 INTRODUCTION 
The previous two sections characterized the effects of the hedgehog defect in the Cys40 mutant 
on the process of skeletal development. The experiments in this section sought to uncover the 
specific mechanism by which hedgehog signaling was disrupted with loss of Wdpcp. 
Pharmacologic and genetic rescue of hedgehog pathway responsive genes and proliferative 
response was used as a read out to show that loss of Wdpcp disrupts hedgehog signaling by 
altering phosphorylation of Gli transcription factors that determines their further post-
translational processing. 
4.2 METHODS 
4.2.1 Generation and culture of MEFs 
MEFs used in these experiments were isolated and expanded from embryos derived from 
WdpcpCys40/+ matings as described in 3.2.2. For all drug treatment experiments, MEFs were 
grown to confluence, trypsinized, and re-plated at full confluence (150,000 cells/cm2) in 
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appropriate size culture well in growth medium for 1 day before changing to starvation medium 
(DMEM supplemented with 0.25% MSC qualified FBS). Previous studies had demonstrated that 
cell cycle arrest as induced by serum starvation and confluence are necessary to induce optimal 
ciliation and hedgehog responsiveness of MEFs (Rohatgi et al., 2007). Following 2 days of 
culture with starvation medium, medium was changed to starvation medium supplemented with 
pharmacological agent dissolved in DMSO (Sigma) for 24 hours. MEFs were fixed for imaging 
or harvested for RNA or protein at this time point. 
All drugs were diluted in DMSO to be added 1:1000. DMSO was added 1:1000 for 
carrier control. Smoothened agonist (SAG) (Calbiochem) was used at 100 nM. Cyclopamine 
(LKT laboratories) was used at 10 uM. GANT61 (Sigma) was used at 50 uM. 3-isobutyl-1-
methylxanthine (IBMX) (Sigma) was used at 2.5 uM. Protein kinase A inhibitor fragment 14-22, 
myristylated trifuloroacetate salt (PKAi) (Sigma) was used at 60 uM.  
For lentiviral infection, MEFs were plated at 100,000 cells/cm2 in growth medium for 1 
day. Medium was changed to lentiviral infection medium consisting of 1:1 lentiviral medium 
isolated from HEK293 lentiviral packaging cultures to DMEM without antibiotics. Polybrene 
was added to transfection medium 1:1000 for a final concentration of 10 ug/mL (Santa Cruz 
Biotech). Infection was allowed to take place for 48 hours. Following infection, medium was 
changed to starvation medium for 3 days. MEFs were fixed for imaging or harvested for RNA or 
protein at this time point. 
4.2.2 Immunofluorescence of primary cilia 
MEFs were cultured in 12 well plates on circular cover slips as described for drug treatments in 
section 4.2.1 to induce ciliogenesis. At end of culture period, MEFs were washed in PBS and 
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fixed with 4% paraformaldehyde for 15 min at room temperature. MEFs were washed in PBS 
before incubation in PBS with 0.1% Triton X-100 (PBST) for 30 minutes at room temperature 
following by blocking with 5% chicken serum (Gibco)  in PBST for 1 hour at room temperature. 
Primary antibodies were diluted in PBS with 5% chicken serum and incubated overnight at 4C. 
Mouse monoclonal antibody against acetylated alpha tubulin (Sigma Clone 6-11-B) is an 
established marker of primary cilia axoneme and was used at 1:500. Rabbit polyclonal antibody 
to centrosomal gamma tubulin (Abcam) is an established marker of basal body of primary cilia 
and was used at 1:200. Following overnight incubation, coverslips were allowed to equilibrate at 
room temperature before washing with PBST followed by incubation with PBST with 5% 
chicken serum with diluted secondaries for 2 hours at room temperature. Chicken secondary 
antibodies labeled with Alexafluor dyes 647 against mouse and 488 against rabbit (Invitrogen) 
were both used at 1:200. Negative controls included omission of primary antibodies and primary 
isotype (Igg) controls. Specific information regarding primary and secondary antibodies is 
included in Appendix A. Nuclei were stained using 4’,6’-Diamidino-2-Phenylindole (DAPI; 
Invitrogen) at 1 ug/mL for 3 minutes following secondaries. Images were acquired on Zeiss 
inverted epifluorescent microscope with 60X objective.  
4.2.3 Generation of Gli mutant lentiviral constructs 
To study the effects of overexpression of truncated Gli3 repressor (Gli3R) and constitutively 
activated Gli2 (Gli2PcgE) on proliferation and hedgehog signaling in Wdpcp deficient MEFs, 
these complementary DNA (cDNA) for these constructs were cloned in the pLenti6 
overexpression vector. A lentivirus containing enhanced green fluorescent protein (EGFP) was 
used as a control. The pLenti6 construct contains HIV 5’ LTR (long terminal repeat) and HIV 3’ 
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LTR for stable integration into the genome of the intervening DNA segment. Expression of the 
inserted cDNA is driven by a constitutively active cytomegalovirus (CMV) promoter. 
Additionally, this vector contains an ampicillin selection gene for bacterial cloning, and a 
blasticidin selection gene for eukaryotic selection.  
Dr. Bing Wang provided the p6 lentivirus construct. The Gli2pcgE cDNA was obtained 
from Addgene courtesy of Dr. Rajat Rohatgi. The Gli3R cDNA was generated from the cDNA 
clone for full-length mouse Gli3 (GeneCopoeia). For construction of the pLenti6-Gli2PcgE-
TRIP lentivirus, DNA primers were designed that included two unique restriction sites for 
cloning in the 5’ end and a 20-24 basepair segment that hybridized to either end of the Gli2PcgE 
cDNA in the 3’ end. The forward primer included restriction enzyme recognition sites for the 
SpeI and SbfI enzymes, while the reverse primer included restriction enzyme recognition sites 
for the BstBI and SalI enzymes. This allowed for insertion of Gli2PcgE in the correct 5’ to 3’ 
orientation.  
These cloning primers were used to carry out PCR amplification of Gli2PcgE from the 
template plasmid obtained from Dr. Rajat Rohatgi with Phusion high fidelity PCR kit (New 
England Biolabs). PCR product size was verified with gel electrophoresis and PCR products 
were digested with DpnI to eliminate residual template plasmid. Following purification with 
PCR clean up kit (Qiagen), PCR products were digested with SpeI followed by SacII. The 
p6lentiEGFP was digested with SpeI and SacII and the digested pLenti6 backbone (~7.4 kbp) 
was gel purified from the EGFP fragment and uncut vector with an agaorse gel purification kit 
(Qiagen). The digested and purified PCR product was added to the digested and purified pLenti6 
backbone at molar concentration of 10:1 and used with a ligation reaction kit (New England 
Biolabs) overnight at room 4C. Ligation product was transformed into OneShot Stbl3 competent 
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cells (Lifetechnologies) with heat shock and transformed colonies selected for on an ampicillin 
agarose plate. Purified mini-prepped plasmids (Qiagen) were digested with SpeI and SacII to 
verify insert and vector size. Vectors were sequence verified with Sanger sequencing to screen 
for unintended mutagenesis. For Gli3R, steps were analogous but SpeI and BstBI enzymes were 
used. Lentiviral construct maps are provided in Appendix A. 
4.2.4 Infection and cell culture of MEFs  
Growth medium containing Dulbecco’s modified E Medium (DMEM) supplemented with 10% 
fetal bovine serum (FBS) and 100 ug/mL (1X) penicillin/Strep/fungizone. Cyclopamine, 
smoothened agonist, GANT61 were dissolved in dimethyl sulfoxide (DMSO) and stored at -20C. 
All drugs diluted in DMSO before being added to cell culture medium in 1:1000 ratio. 
 
Figure 24. Verification of lentiviral tropism in MEFs. 
Control (A) and Cys40 (B) MEFs both exhibited expression of EGFP after infection with pLenti6-EGFP-TRIP 
lentivirus. Efficiency of infection was similar between control and Cys40 MEFs. 
4.2.5 Edu proliferation assay 
The Click-iT Plus Edu 594 assay was used to quantify cell proliferation over final 24 hours of 
cell culture as described in section 4.2.1. Following serum starvation period, 10 mM EdU 
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dissolved in PBS was added to culture medium at 1:1000 for a final concentration of 10 uM. 
Following fixation with 4% paraformaldehyde for 15 min at room temperature, EdU staining was 
performed per the manufacturer’s protocol (Lifetechnologies). Hoechst staining was performed 
to identify all nuclei. Images were acquired on Zeiss inverted epifluorescent microscope with 
10X objective. Three fields were captured for each treatment condition and presented images are 
representative. 
4.2.6 Western Blotting 
Protein was isolated from a well of a 6 well plate using a Total Protein Isolation Kit (Millipore) 
supplemented with Halt protease and phosphatase inhibitor cocktail and 5 mM EDTA. Sample 
preparation and Western blot for Gli3 was carried out as described in section 2.2.6. Three 
independent biological replicates were completed for each condition and each blot was done in 
duplicate. Images presented are representative. 
4.2.7 RNA isolation and qPCR 
RNA isolation, reverse transcription, and qPCR assays were performed as described in section 
2.2.6, with 3 experimental replicates each containing two pooled biological replicates to obtain 
sufficient RNA concentration. Ccnd1 was used as a marker of cell proliferation. Activity of the 
hedgehog pathway was measured with Gli1 and Hhip activity. Relative expression was 
determined using validated primers (Appendix A) and the ΔΔCT method, with expression 
reported relative to endogenous control hypoxanthine-guanine phosphoribosyltransferase (Hprt). 
Statistics were performed as described in Section 2.2.8. 
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4.3 RESULTS 
4.3.1 MEFs lacking Wdpcp are not responsive to Smo agonists 
Control MEFs respond to SAG stimulation with increased expression of Gli1 (p<0.05) and 
increased cell proliferation as assayed by EdU staining (Figure 25). Cys40 MEFs fail to increase 
Gli1 expression, Ccnd1 expression, or proliferation as assayed by EdU staining in response to 
SAG stimulation. 
 
Figure 25. Cys40 MEFs display decreased responsiveness to modulation of Smo activity.  
Treatment of control MEFs with Smoothened agonist (SAG) results in increased proliferation while treatment of 
Cys40 MEFs with SAG has no effect on proliferation as assayed by EdU incorporation. Treatment of control MEFs 
with Smoothened antagonist cyclopamine (CYC) results in decreased proliferation while treatment of Cys40 MEFs 
with cyclopamine has no effect on proliferation as assayed by EdU incorporation (A). Increasing doses of SAG 
treatment result in increasing expression of hedgehog reporter gene Gli1 in controls MEFs versus no significant 
change in Cys40 MEFs (B). Increasing doses of cyclopamine treatment result in decreasing expression of hedgehog 
reporter gene Gli1 in control MEFs versus no significant change in Cys40 MEFs (C). Error bars represent one 
standard deviation. Effect of drug treatment within a genotype is calculated using Student’s t-test with * for p<0.05, 
** for p<0.01, *** for p<0.001. 
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4.3.2 Direct inhibition of Gli silence ectopic activation of hedgehog pathway due to Wdpcp 
loss 
Treatment with direct Gli inhibitor GANT61 resulted in reduction of proliferation of both Cys40 
MEFs as well as control MEFs as assayed by EdU positive MEFs after 24 hours of treatment 
(Figure 26A). Additionally, there is a significant reduction in the expression of both hedgehog 
reporter gene Gli1 and proliferation reporter gene Ccnd1 for both Cys40 and control MEFs 
(Figure 26B,C). 
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Figure 26. Direct Gli inhibition suppresses hedgehog pathway and proliferation.  
Treatment of Cys40 and control MEFs with direct Gli inhibitor GANT61 (50 uM) suppresses proliferation as 
assayed by EdU incorporation after 24 hours of cell culture treatment (A). Decreased proliferation correlates with 
decreased expression of hedgehog responsive gene Gli1 (B) and of proliferation marker Ccnd1 (C). All panels are at 
same scale and scale bar is 10 um. Expression is expressed relative to Hrpt. Error bars represent one standard 
deviation. Effect of drug treatment within a genotype is calculated using Student’s t-test with * for p<0.05, ** for 
p<0.01, *** for p<0.001. 
4.3.3 Lentiviral overexpression of Gli3R silences ectopic activation of hedgehog pathway 
due to Wdpcp loss 
Having determined that direct inhibition of all Gli-DNA interactions was capable of inhibited 
hedgehog pathway activity and proliferation, it was hypothesized that overexpression of the Gli3 
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repressor form could have a similar silencing effect on hedgehog pathway activity and 
proliferation in Cys40 MEFs. Over expression of the repressor form of Gli3 would essentially be 
a rescue of the Gli3 processing defect present in Cys40 MEFs. Transfection with lentivirus that 
overexpresses the repressor form of Gli3 would correct the decreased Gli3 repressor:activator 
ratio that results from deficient Gli3 processing in Cys40 mutants. As hypothesized, lentiviral 
overexpression of the truncated repressor of Gli3 silenced both hedgehog pathway activity in 
Cys40 MEFs as assayed by Gli1 mRNA levels (p<0.05) and proliferation as assayed by EdU 
staining (Figure 27). Reduction of Ccnd1 mRNA levels was not significantly reduced but may be 
with blasticidin selection to ensure higher enrichment of transfected MEFs.  
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Figure 27. Lentiviral overexpression of Gli3R suppresses hedgehog pathway and proliferation in Cys40 
MEFs. 
Infection of Cys40 and control MEFs pLenti6-Gli3R-TRIP lentivirus for overexpression of Gli3R suppresses 
proliferation as assayed by EdU incorporation after 24 hours of cell culture treatment (A). Decreased proliferation 
correlates with decreased expression of hedgehog responsive gene Hhip (B) and of proliferation marker Ccnd1 (C). 
All panels are at same scale and scale bar is 10 um. Error bars represent one standard deviation. Effect of drug 
treatment within a genotype is calculated using Student’s t-test with * for p<0.05, ** for p<0.01, *** for p<0.001. 
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4.3.4 MEFs lacking Wdpcp have impaired ciliogenesis 
Immunofluorescence staining with acetylated alpha tubulin for the ciliary axoneme and gamma 
tubulin for the ciliary basal body reveals Cys40 MEFs fail to form functional primary cilia 
(Figure 28). This is consistent with the impaired responsiveness to Smo activation and inhibition 
and disrupted Gli3 processing observed in Cys40 forelimb buds. 
 
Figure 28. Cys40 MEFs display defective ciliogenesis.  
Immunofluorescence staining of MEFs for cilia axoneme marker, acetylated alpha tubulin (red) and ciliary basal 
body/centrosome marker gamma tubulin (green) reveals deficient ciliogenesis in Cys40 MEFs. White scale bar 
represents 2 uM. Scale is same in both images. 
 
 
4.3.5 Hedgehog signaling and Gli3 processing are responsive to PKA modulation in MEFs 
lacking Wdpcp 
Because PKA is a known negative regulator of the hedgehog signaling pathway, we 
hypothesized that Gli3 processing could be rescued in Cys40 MEFs with PKA stimulation with 
the phosphodiesterase inhibitor IBMX. Treatment of both Cys40 and control MEFs with IBMX 
resulted in complete depletion of full length Gli3 and accumulation of Gli3R as well as 
suppressed expression of hedgehog reporter gene Gli1 (p<0.05). Conversely, inactivation of 
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PKA with treatment with PKAi resulted in increased accumulation of full length Gli3. 
Expression of hedgehog reporter gene Gli1 did not increase significantly with PKAi treatment, 
likely do to the fact that Gli2FL and not Gli3FL is the primary activating transcription factor 
(Figure 29). 
 
Figure 29. PKA signaling affects Gli processing independent of Wdpcp.  
Gli3 processing is deficient in untreated Cys40 MEFs compared to control MEFs. Treatment of MEFs with PKAi 
inhibits Gli3 processing in both Cys40 and control MEFs. Treatment of MEFs with IBMX facilitates Gli3 
processing in both Cys40 and control MEFs (A). Expression of hedgehog reporter Gli1 follows Gli3 processing and 
Gli3R levels, with significant reductions in Gli1 expression in MEFs treated with IBMX. Error bars represent one 
standard deviation. Effect of drug treatment within a genotype is calculated using Student’s t-test with * for p<0.05, 
** for p<0.01, *** for p<0.001. 
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4.3.6 MEFs lacking Wdpcp respond to PKA signaling 
 
Figure 30. PKA signaling affects proliferation independent of Wdpcp.  
Treatment of both control and Cys40 MEFs with PKAi results in increased proliferation as assayed by EdU 
incorporation. Treatment of both control and Cys40 MEFs with IBMX results in decreased proliferation as assayed 
by EdU incorporation (A). Expression of proliferation marker Ccnd1 correlates with observed changes in 
proliferation observe with EdU staining, with PKAi treatment increasing Ccnd1 expression, and IBMX treatment 
suppressing Ccnd1 expression. All panels are at same scale and scale bar is 10 um. Error bars represent one standard 
deviation. Effect of drug treatment within a genotype is calculated using Student’s t-test with * for p<0.05, ** for 
p<0.01, *** for p<0.001. 
 
Control MEFs and Cys40 MEFs both respond to stimulation of PKA via IBMX treatment with 
increased proliferation as assayed by EdU staining and increased expression of proliferation 
marker gene Ccnd1 (Figure 30). This indicates that PKA modulation is able to affect hedgehog 
target proliferation regardless of presence of Wdpcp or primary cilia. 
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4.3.7 Gli2 mutants mimicking Gli Pc-g phosphorylation rescue loss of hedgehog 
activation due to Wdpcp loss 
Having demonstrated that PKA can effect Gli3 processing and hedgehog signaling, we 
hypothesized that mimicking the amino terminal phosphorylation shown previously to be 
necessary for activation of Gli transcription factors (Niewiadomski et al., 2014) might be able to 
rescue the deficiency in hedgehog activation present in MEFs lacking Wdpcp. Using site directed 
mutagenesis, we generated the pLenti6-Gli2pcgE-TRIP with the relevant amino terminal serine 
and threonine residues (Pcg) mutated to negatively charged aspartic acid residues to mimic 
phosphorylation (Figure 3).  Cys40 MEFs infected with pLenti6-Gli2pcgE-TRIP for 
overexpression of constitutively phosphorylated Gli2 displayed increased Hhip expression 
(Figure 31), indicating that loss of Wdpcp may disrupt the ability of PKA to provide 
phosphorylation of the amino terminal residues in Gli2 necessary for hedgehog activation. 
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Figure 31. Lentiviral overexpression of activated Gli2 increases proliferation and hedgehog activity in Cys40 
MEFs. 
Infection of Cys40 and control MEFs pLenti6-Gli2PcgE-TRIP lentivirus for overexpression of activated Gli2 
increases proliferation as assayed by EdU incorporation after 24 hours of cell culture treatment (A). Increased 
proliferation correlates with increased expression of hedgehog responsive gene Hhip (B) and of proliferation marker 
Ccnd1 (C). All panels are at same scale and scale bar is 10 um. Error bars represent one standard deviation. Effect of 
drug treatment within a genotype is calculated using Student’s t-test with * for p<0.05, ** for p<0.01, *** for 
p<0.001. 
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4.4 DISCUSSION 
These findings also demonstrate that PKA can rescue the Wdpcp loss of function and potentially 
other primary cilia mutants, suggesting a role for primary cilia in Gli phosphorylation. Our 
finding that stimulation of PKA is able to suppress expression of hedgehog target gene Gli1 
(Figure 29B) and restore formation of truncated Gli3 repressor (Figure 29A) in MEFs lacking 
Wdpcp is in accordance with previous findings that PKA functions as a negative regulator of 
hedgehog signaling in cells with disrupted ciliogenesis (Wen et al., 2010). More recently, a 
number of PKA has also been implicated in hedgehog activation through phosphorylation of 
amino terminal residues (Figure 3) (Niewiadomski et al., 2013). Our findings that the pLenti6-
Gli2PcgE-TRIP lentivirus is able to increase expression of hedgehog pathway target gene Hhip 
MEFs lacking functional Wdpcp (Figure 31) suggests that primary cilia and Wdpcp may facilitate 
the PKA mediated phosphorylation of Gli2 necessary for hedgehog activation. Recent studies 
have suggested that the primary cilium may regulate hedgehog signaling by serving as a center 
where the action of PKA on Gli2 and Gli3 is tightly regulated. PKA is localized to the base of 
the primary cilium (Tuson et al., 2011), and recent studies have identified G-protein coupled 
receptors that activate the PKA pathway, are localized to the primary cilium, and modulate 
hedgehog pathway activation (Mukhopadhyay and Rohatgi, 2014; Mukhopadhyay et al., 2013). 
The role of Wdpcp in constraining these receptors to the primary cilium and regulating their 
activity bears future investigation in light of our findings. 
These findings suggest that post-translational modification occurring subsequent to 
phosphorylation may not require cilia. Sumoylation, ubiquitinylation, phosphorylation and many 
other post-translational modifications are known to play important roles in the turnover, 
processing, and activation of Gli transcription factors (Cox et al., 2010; Kent et al., 2006; 
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Mukhopadhyay and Rohatgi, 2014). Future studies with mutant forms of Gli will be essential to 
dissecting the role of different cilia associated and hedgehog associated proteins in this pathway. 
Observing the effects of these mutants on processing, subcellular localization, and expression of 
target genes will yield new insights to mechanics of this critical signaling pathway.  
 
Figure 32. Wdpcp functions at or above PKA in the hedgehog pathway. 
The diminished response of cells lacking Wdpcp to both Smo (blue) agonism and antagonism indicates that Wdpcp 
functions downstream of Smo in the hedgehog pathway. The ability of PKA modulation to effect hedgehog 
signaling output and Gli3 processing independently of Wdpcp (purple) indicates that Wdpcp acts at or above PKA 
(red) in the processing of Gli transcription factors (brown) in the hedgehog pathway. 
 89 
4.5 CONCLUSION 
Loss of Wdpcp in Cys40 MEFs affects hedgehog signaling via disruption of formation of the 
primary cilium. Disruption of the primary cilium results in deficient Gli3 processing to the 
repressor form as well as deficient activation of Gli2/3 to the activator form as evidenced by the 
decreased responsiveness of Cys40 MEFs to both Smo agonists and antagonist. Furthermore, this 
data suggest that Wdpcp and the primary cilium function somewhere downstream of Smo in the 
hedgehog signaling pathway (Figure 32). Gli3 processing in the Cys40 MEFs can be rescued 
with application of the phosphodiesterase inhibitor and PKA activator IBMX. As expected, 
increased processing of Gli3 to the repressor form as stimulated by PKA suppresses activation of 
the hedgehog pathway due to the increased levels of repressor. Conversely, PKAi application 
inhibits Gli3 processing in both Cys40 and control MEFs (Figure 29A). However, no significant 
increase in expression of hedgehog pathway target gene Gli1 is observed with PKAi treatment 
(Figure 29B), suggesting that PKA functions primarily as a positive regulator of Gli3 repressor 
processing to repressor and not as a negative regulator of Gli activator formation. While no 
significant effects on hedgehog pathway activity were observed with PKAi treatment, it should 
be noted that PKAi treatment did result in significant increase in proliferation (Figure 30). 
Proliferation is a multifactorial readout and PKA is a promiscuous kinase, making it difficult to 
draw specific conclusions about the effects PKAi treatment and the role of PKA from these 
findings. However, combined with the findings of alteration of Gli3 processing and changes in 
Gli1 expression (Figure 29). The ability of PKA treatment to affect proliferation of both Cys40 
and control MEFs can be interpreted to indicate that PKA acts at the same level as or 
downstream of Wdpcp in control of proliferation. The final experiments in this series examine 
the effect of lentiviral overexpression of a constitutively activated form of Gli2 with sites Pc-g 
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modified to mimic phosphorylation. The increased expression of hedgehog pathway target gene 
Hhip (Figure 31B) suggests providing phosphorylation of Gli2 on residues Pc-g is able to rescue 
the activation lost with loss of Wdpcp and disruption of the primary cilium. This result suggests 
that Wdpcp acts upstream of Gli2Pc-gE phosphorylation in the formation of the activator form of 
Gli. 
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5.0  IMPACT AND FUTURE DIRECTIONS 
5.1 IMPACT 
5.1.1 Skeletal Development and Tissue Engineering 
These findings support previous findings that repression of hedgehog signaling is necessary for 
initiation of cartilage condensation and chondrogenesis. These findings also support a role for 
primary cilia in transducing the hedgehog signal necessary for osteogenesis.  The findings of this 
study suggest that repression of hedgehog signaling will enhance chondrogenesis and suppress 
hypertrophic differentiation. While temporal activation of hedgehog signaling will suppress 
chondrogenesis, it will eventually promote hypertrophic chondrocyte differentiation and 
osteogenesis in established chondrocytes. 
5.1.2 Osteoarthritis 
Hedgehog signaling is known to play an important role in adult homeostasis of cartilage. 
Dysfunctional activation of hedgehog signaling is associated with the accelerated development 
of osteoarthritis (Lin et al., 2009). The primary cilium is also believed to be an important 
mediator of mechanosensation in cartilage and bone (Yuan et al., 2015). This work demonstrates 
that Wdpcp is necessary for normal cartilage homeostasis in mice. Additionally, it was shown 
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that dysfunction resulting from loss of Wdpcp is associated with increased hedgehog signaling. 
This suggests that therapeutic strategies that prevent loss of primary cilia and/or repress 
hedgehog signaling may be able to restore cartilage homeostasis. 
5.1.3 Cancer 
Dysfunctional hedgehog signaling is a hallmark of many malignancies including basal cell 
carcinoma, medulloblastoma, pancreatic cancer, chondrosarcoma, colorectal, and ovarian 
cancers (Amakye et al., 2013). 98% of basal cell carcinomas result from a mutation in the 
hedgehog receptor Ptch (Iwasaki et al., 2012). While the majority of these tumors are cured by 
resection, in the cases where this has been delayed or is technically difficult (e.g. on a sensitive 
area of the face) medical therapies would be useful. Indeed, the first hedgehog pathway 
therapeutic, vismodegib, passed clinical trials and received FDA approval for this indication in 
late 2011. While some tumors such as basal cell carcinoma have shown significant responses to 
Vismodegib, clinical trials investigating the therapeutic potential of Smo antagonists for other 
tumor types such as pancreatic cancers and chondrosarcoma have been discontinued due to 
disappointing results (Amakye et al., 2013).  
With mutations in over 500 of an estimated 20,000 human genes or homologs identified 
as disrupting ciliogenesis, low activation of hedgehog signaling that results from disruption of 
primary cilia may play a larger role in malignancy than is currently appreciated. Deciphering the 
role of the primary cilium and associated components in regulating hedgehog signaling via Gli 
modification will open the door for the design of targeted therapeutics that modulate hedgehog 
signaling downstream of Smo. This work demonstrates a role for Wdpcp in PKA mediated 
phosphorylation of Gli2 and Gli3 for both the activation and repression of hedgehog signaling, 
 93 
suggesting that Gli phosphorylation is a key regulatory step downstream of or at the same level 
as the primary cilium in the hedgehog pathway. Our findings suggest that targeting Gli 
phosphorylation could be a significantly more effective strategy for repression of hedgehog 
signaling than Smo inhibition. However, PKA is a promiscuous kinase and further work to 
clarify the binding partners that mediate site-specific phosphorylation of Gli is necessary to 
uncover hedgehog pathway specific targets. 
5.2 FUTURE DIRECTIONS 
The effect of postnatal deletion of Wdpcp on the homeostasis of adult chondrocytes is an area of 
current investigation. Col2a1-CreERT:Wdpcpflow/flox mice with chondrocyte-specific deletion of 
Wdpcp induced with tamoxifen injection at 6 weeks of age display drastic changes in gait and 
osteoarthritic symptoms versus Col2a1-CreERT;Wdpcp+/+ mice injected at the same time at 6 
months post injection. Further characterization of this phenotype is underway.  
Having observed the delay in ossification in the Col2a1-CreERT;WdpcpCys40/Flox mice, 
current investigations are examining the effect of non-skeletal tissues on the process of 
osteogenesis. Vascular invasion of the hypertrophic zone at the primary site of ossification is 
necessary for normal osteogenesis. Endothelial specific deletion of Wdpcp utilizing the Tie2-Cre 
mouse line crossed to the WdpcpFlox mice will be used to investigate the role of Wdpcp in the 
vascularization of bone. 
Having investigated and described the appendicular skeletal defect of the Cys40 mutant, 
the craniofacial and axial skeletal defects remain areas for future investigation. We note that 
E13.5 Cys40 embryos display facial clefting (Figure 33). Our initial characterization of the 
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disruption of the hedgehog pathway in Cys40 mice will facilitate investigations into the 
mechanism of these phenotypes. For example, the craniofacial skeleton is derived primarily from 
neural crest cells, a population has been demonstrated to be specifically labeled in lineage tracing 
studies by Wnt1-Cre (Firulli et al., 2014). To determine whether the craniofacial defects 
observed are due to cell autonomous function of Wdpcp in these cells or due to the function of 
Wdpcp in cells outside this population, Wnt1-cre mice may be crossed to Wdpcpflox mice to 
generate mice with a conditional deletion of Wdpcp in neural crest cells. These studies would 
provide insights into the mechanisms of craniofacial skeleton morphogenesis and facial clefting 
and may suggest potential therapies and/or risk factors associated with facial clefting. 
 
Figure 33. Craniofacial skeletal defects in Cys40 mutant mice. 
E13.5 Cys40 mutant mice display facial clefting versus matched littermate controls. Recapitulation of cleft 
phenotype is variable in Prx1-Cre;WdpcpCys40/Flox mice. 
 
 In the axial skeleton, the effects of Wdpcp deletion on degeneration of the intervertebral 
disc beg investigation. Recent investigations have demonstrated important roles for hedgehog 
 95 
signaling in both the development and maintenance of adult homeostasis of the intervertebral 
disc (Dahia et al., 2012). The Noto-CreERT mouse line expresses an inducible Cre recombinase 
specifically in the notochord, and later in adults, specifically in the nucleus pulposus of the 
intervertebral discs (Ukita et al., 2009). Breeding this Cre line to Wdpcpflox mice would generate 
mice with an inducible nucleus pulposus specific deletion of Wdpcp. It would be informative to 
determine the effects of Wdpcp los and primary cilium disruption in these tissues because it has 
not been studied. 
Our studies highlight the central importance of Gli phosphorylation in regulation of 
hedgehog signaling output, and demonstrate that further studies into the specific role of Wdpcp 
and the primary cilium in regulating the process of Gli phosphorylation are warranted. Residue 
specific mutants of Gli3 both with mutations of phosphorylatable serine and threonine to 
unphosphorylatable alanine and mutations of serine and threonine to glutamic acid to mimic 
phosphorylation should be generated and studied for their ability to be processed to shortened 
repressor form in absence of primary cilia.  The subcellular and ciliary localization of GFP 
tagged versions of these mutant Gli forms would yield insights into the interactions that govern 
the site-specific phosphorylation of Gli. Immunoprecipitation studies utilizing these mutated 
forms of Gli would provide insights into downstream interactions and how site-specific 
phosphorylation of Gli leads to formation of activator versus repressor. These studies will 
provide essential information for the design of therapeutics that modulate Gli phosphorylation 
and alter hedgehog pathway output.  
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APPENDIX A 
A.1 RT-PCR PRIMERS 
Gene  Reference Sequence Accession 
Gli1 5’ MGH PrimerBank CCAAGCCAACTTTATGTCAGGG NM_010296 
Gli1 3’ MGH PrimerBank AGCCCGCTTCTTTGTTAATTTGA NM_010296 
Ptch1 5’ MGH PrimerBank GCCTTCGCTGTGGGATTAAAG NM_008957 
Ptch1 3’ MGH PrimerBank CTTCTCCTATCTTCTGACGGGT NM_008957 
Wdpcp 5’ MGH PrimerBank GCTTGACTGAACTACACCTGTG NM_145425 
Wdpcp 3’ MGH PrimerBank TGAGTGTCCAAGGATAATCTCGT NM_145425 
Col2a1 5’ MGH PrimerBank GGGAATGTCCTCTGCGATGAC NM_031163 
Col2a1 3’ MGH PrimerBank GAAGGGGATCTCGGGGTTG NM_031163 
Grem1 5’ Benazet et al 2009 CCCACGGAAGTGACAGAATGA NM_011824 
Grem1 3’ Benazet et al 2009 AAGCAACGCTCCCACAGTGTA NM_011824 
Sdc3 5’ MGH PrimerBank AGAGGCCGGTGGATCTTGA NM_011520 
Sdc3 3’ MGH PrimerBank CTCCTGCTCGAAGTAGCCAGA NM_011520 
Cdh2 5’ MGH PrimerBank AGCGCAGTCTTACCGAAGG NM_007664 
Cdh2 3’ MGH PrimerBank TCGCTGCTTTCATACTGAACTTT NM_007664 
Sox9 5’ MGH PrimerBank AGTACCCGCATCTGCACAAC NM_011448 
Sox9 3’ MGH PrimerBank ACGAAGGGTCTCTTCTCGCT NM_011448 
Bmp4 5’ Benazet et al 2009 AGCCGAGCCAACACTGTGA NM_007554 
Bmp4 3’ Benazet et al 2009 GTTCTCCAGATGTTCTTCGTGATG NM_007554 
Ccnd1 5’ Lopez-Rios 2012 CAGACGTTCAGAACCAGATTC NM_007631 
Ccnd1 3’ Lopez-Rios 2012 CCCTCCAATAGCAGCGAAAAC NM_007631 
Shh 5’ MGH PrimerBank AAAGCTGACCCCTTTAGCCTA NM_009170 
Shh 3’ MGH PrimerBank TTCGGAGTTTCTTGTGATCTTCC NM_009170 
Msx2 5’ MGH PrimerBank TTCACCACATCCCAGCTTCTA NM_013601 
Msx2 3’ MGH PrimerBank TTGCAGTCTTTTCGCCTTAGC NM_013601 
Hhip 5’ MGH PrimerBank CCACCACACAGGATCTCTCC NM_020259 
Hhip 3’ MGH PrimerBank TGAAGATGCTCTCGTTTAAGCTG NM_020259 
Hprt 5’ MGH PrimerBank TCAGTCAACGGGGGACATAAA NM_013556 
Hprt 3’ MGH PrimerBank GGGGCTGTACTGCTTAACCAG NM_013556 
Acan 5’ MGH PrimerBank CCTGCTACTTCATCGACCCC NM_007424 
Acan 3’ MGH PrimerBank AGATGCTGTTGACTCGAACCT NM_007424 
Col9a1 5’ MGH PrimerBank CGACCGACCAGCACATCAA NM_007740 
Col9a1 3’ MGH PrimerBank AGGGGGACCCTTAATGCCT NM_007740 
Ocn 5’ MGH PrimerBank CTGACCTCACAGATCCCAAGC NM_007541 
Ocn 3’ MGH PrimerBank TGGTCTGATAGCTCGTCACAAG NM_007541 
Col1a1 5’ MGH PrimerBank TAAGGGTCCCCAATGGTGAGA NM_007742 
Col1a1 3’ MGH PrimerBank GGGTCCCTCGACTCCTACAT NM_007742 
Runx2 5’ MGH PrimerBank GGTGGTCCGCGATGATCTC NM_009820 
Runx2 3’ MGH PrimerBank GAGGGCACAAGTTCTATCTGGA NM_009820 
Osx 5’ MGH PrimerBank ATGGCGTCCTCTCTGCTTG NM_130458 
Osx 3’ MGH PrimerBank TGAAAGGTCAGCGTATGGCTT NM_130458 
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